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1. General Experimental Details 
All required fine chemicals were used directly without purification unless mentioned. 
All air- and water-sensitive reactions were carried out in flame-dried glassware under 
nitrogen atmosphere using standard Schlenk manifold technique. 1H and 13C Nuclear 
Magnetic Resonance (NMR) spectra were acquired at various field strengths as 
indicated, and were referenced to CHCl3 (7.27 and 77.0 ppm for 1H and 13C 
respectively) or DMSO (2.50 and 39.5 ppm for 1H and 13C respectively). Chemical 
shifts (δ) are quoted in parts per million (ppm) and coupling constants (J) are in Hertz 
(Hz). Letters are assigned to protons in chemical structures for 1H NMR assignment 
purposes only (assigning in alphabetical order from downfield to upfield). Carbons 
attached to boron atoms are often not observed due to quadrupolar relaxation. 11B NMR 
spectra were measured using boron-free quartz NMR tubes, and recorded with complete 
proton decoupling using BF3·Et2O (0.0 ppm) as an external standard. High-resolution 
mass spectra (HRMS) were recorded using Electron Spray Ionization (ESI). All IR data 
was obtained on a Perkin-Elmer Spectrum One FT-IR spectrometer. Optical rotations 
were obtained on a Perkin-Elmer 241MC polarimeter. Analytical TLC: Aluminium-
backed plates pre-coated (0.25 mm) with Merck Silica Gel 60 F254. Compounds were 
visualized by exposure to UV-light or and/or developed with potassium permanganate 
or anisaldehyde. Flash column chromatography was performed using Aldrich Silica Gel 
60 (40-63 µm). Chiral HPLC was performed using a Diacel Chiralpak IA or IB column 
(4.6 × 250 mm × 5 µm) fitted with the respective guard (4 × 10 mm) and monitored by 
DAD (Diode Array Detector). Chiral SFC was performed using a Chiralpak IA, IB, IC 
or Whelk-01 column (4.6 × 250 mm × 5 µm) on a Waters TharSFC system and 
monitored by DAD (Diode Array Detector). Chiral GC was performed using a 
Chiraldex β-DM column and monitored by FID (Flame Ionisation Detector). Solvents 
were purified by standard methods. TMEDA was distilled over CaH2. (–)-Sparteine was 
obtained from the commercially available sulfate pentahydrate salt (99%, Acros) and 
isolated according to literature procedure[1]. (+)-Sparteine was purchased from BOC 
sciences and was distilled over CaH2 prior to use. The sparteine free base readily 
absorbs atmospheric carbon dioxide (CO2) and should be stored under argon/nitrogen at 
−20 °C in a Schlenk tube.  (+)-Sparteine surrogate was synthesised from (–)-cytisine 
(purchased from Carbosynth) according to literature procedure[2] and was purified by 
kugelrohr distillation no more than 24 h prior to its use. s-BuLi was purchased from 
	 SI-4 
Acros. n-BuLi and t-BuLi were purchased from Sigma-Aldrich. The molarity of 
organolithium solutions was determined by titration using benzylbenzamide[3]. 
Anhydrous DMF was purchased from Acros and stored over activated 4Å molecular 
sieves. 2-Isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (i-PrOB(pin)) and 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU) were purchased from Sigma-Aldrich and 
distilled under reduced pressure prior to their use. (R)-2-methylbutane-1,4-diol (14) was 
purchased from TCI. In situ IR monitoring was performed on a ReactIR15 instrument, 
equipped with a DST 9.5mm x 1.5m x 305mm probe with a DiComp (Diamond) sensor 
and a gold seal. For reverse phase purification of 37, flash chromatography was 
performed on a Grace Discovery Sciences Reveleris Prep System with a Phenomenex 
Luna 12 g C18(2) 100 Å AXIA packed column. The instrument was set to monitor the 
ELSD signal. Flow rates were 14 mL / min. The mobile phases used were 0.05 % 
formic acid in water for the aqueous phase and 0.05 % formic acid in MeCN for the 
organic phase. The gradient was from 5 % organic phase for 5 minutes at the start to 40 
% organic phase over 10 minutes, then holding at 40 % organic phase for 10 minutes 
before rising to 80 % organic phase over 10 minutes, with 10 minutes at 100 % organic 
phase followed by 5 minutes at 5 % organic phase. 
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2. Model Studies for the Lithiation-Borylation with Boronic Ester 7 
2.1. Starting Material Synthesis 
3-Phenylpropyl 2,4,6-triisopropylbenzoate (8) 
 
To a solution of 3-phenyl-1-propanol (0.90 g, 6.64 mmol, 1.10 equiv.) in THF (25 mL, 
0.25 M) were added Ph3P (1.74 g, 6.64 mmol, 1.10 equiv.) and 2,4,6-
triisopropylbenzoic acid (1.50 g, 6.04 mmol, 1.00 equiv.). The mixture was cooled to 
0 °C, then diisopropylazadicarboxylate (1.31 mL, 6.64 mmol, 1.10 equiv.) was added 
dropwise. The solution was stirred for 30 min at 0 °C, then it was warmed to room 
temperature and stirred for 4 h. Saturated NH4Cl (10 mL) was added and the layers 
were separated. The organic layer was washed with Brine (2 x 10 mL) and the 
combined aqueous layers were extracted with Et2O (3 x 10 mL). The organic layers 
were combined, dried over MgSO4 and concentrated under vacuum. The crude product 
was triturated with petrol to remove Ph3P=O, then it was purified by column 
chromatography on silica gel, eluting with petrol:EtOAc 95:5 to 90:10, to give 8 as a 
colourless oil (2.10 g, 95%). 1H NMR (400 MHz, CDCl3): δ = 7.34-7.18 (5H, m), 7.00 
(2H, s), 4.34 (2H, t, J 6.5 Hz), 2.88 (3H, sept, J 6.9 Hz), 2.75 (2H, t, J 7.8 Hz), 2.06 
(2H, dt, J 7.8, 6.5 Hz), 1.27 (12H, d, J 6.9 Hz), 1.24 (6H, d, J 6.9 Hz). 13C NMR (100 
MHz, CDCl3): δ = 170.9 (C=O), 150.1 (C), 144.7 (2 x C), 141.1 (C), 130.6 (C), 128.5 (2 
x CH), 128.4 (2 x CH), 126.1 (CH), 120.9 (2 x CH), 64.2 (CH2), 34.4 (CH2), 32.3 (CH), 
31.5 (2 x CH), 30.4 (CH2), 24.2 (4 x CH3), 23.9 (2 x CH3). Data in accordance with the 
literature.[4]  
Ph O
O
Ph OH
TIBOH
PPh3, DIAD
THF, 0 °C
95%
8
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tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolidine-1-carboxylate 
(7) 
 
N-Boc-pyrrolidine (1.00 g, 5.84 mmol, 1.00 equiv.) and TMEDA (1.1 mL, 7.00 mmol, 
1.20 equiv.) were dissolved in Et2O (50 mL). The solution was cooled to –78 °C and s-
BuLi (1.3 M in hexanes, 6.00 mL, 7.00 mmol, 1.20 equiv.) was added dropwise. The 
solution was stirred for 3 h at –78 °C, then i-PrOB(pin) (1.63 g, 8.80 mmol, 1.30 equiv.) 
was added dropwise. The solution was stirred for 1 h at –78 °C, then allowed to warm 
up to room temperature slowly. Aqueous 1 M HCl (50 mL) was added and the layers 
were separated. The organic layers were washed with Brine (3 x 20 mL) and the 
combined aqueous layers were extracted with Et2O (3 x 50 mL). The organic layers 
were combined, dried over MgSO4 and concentrated under vacuum. The crude product 
was purified by fast column chromatography on silica gel, eluting with petrol:EtOAc 
85:15, to give 7 as a white solid (1.20 g, 69%). 1H NMR (500 MHz, DMSO-d6, 90°C): 
δ = 3.23 (1H, m), 3.14 (1H, m), 2.80 (1H, m), 1.87 (2H, m), 1.74 (2H, m), 1.37 (9H, s), 
1.19 (12H, m). 13C NMR (125 MHz, DMSO-d6, 90°C): δ = 83.48 (2 x C), 78.54 (C), 
46.42 (CH2), 28.72 (3 x CH3), 25.37 (CH2), 25.18 (4 x CH3), 24.83 (CH2). C=O peak 
not observed. 11B NMR (96 MHz, CDCl3): δ = 33. Data in accordance with the 
literature.[5] 
Resolution between the enantiomers of 7 was achieved using chiral SFC analysis 
(Whelk 01 column, 10% IPA/hexane – iso 20%, 4 mL/min, 125 bar). tR = 3.53 (R), 4.47 
(S). 
 
 
  
N B(pin)
Boc
N
Boc
(i) s-BuLi, TMEDA
(i) Et2O, –78 °C
(ii) i-PrOB(pin)
69%
7
N
Boc
B(pin)
7
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2.2. Optimisation of the Reaction Conditions 
 
 
General Procedure for the Lithiation-Borylation Between TIB ester 8 and boronic 
ester 7 – GP1 
8 (130 mg, 0.36 mmol, 1.10 equiv.) and TMEDA (0.05 mL, 0.32 mmol, 1.00 equiv.) 
were dissolved in Et2O (3.5 mL). The solution was cooled to –78 °C and s-BuLi (1.3 M 
in hexanes, 0.28 mL, 0.32 mmol, 1.00 equiv.) was added dropwise. The solution was 
stirred for 3 h at –78 °C, then 7 (100 mg, 0.33 mmol, 1.05 equiv.) was added, dissolved 
in Et2O (0.5 mL). The solution was stirred for 45 min at –78 °C, after which 11B NMR 
analysis of the crude mixture showed complete formation of boronate complex 9 [11B 
NMR (92.6 MHz, no solvent) δ = 7]. For conditions for the 1,2-metallate rearrangement 
from 9 to 10, see Table 1 below. 
 
  
Ph OTIB
8
N B(pin)
Boc 7
Ph OTIB
9
B(pin)
N
Boc
Li
Migration
Conditions
N
Boc
Ph
B(pin)
10
(i) s-BuLi, TMEDA
(i) Et2O, –78 °C
(ii)
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Table 1. Optimisation of migration conditions from ate complex 9 to boronic ester 10 
 
 
tert-Butyl 2-(3-phenyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propyl) 
pyrrolidine-1-carboxylate (10) 
 
8 (200 mg, 0.55 mmol, 1.30 equiv.) and TMEDA (59 mg, 0.076 mL, 0.51 mmol, 
1.20 equiv.) were dissolved in Et2O (5.5 mL). The solution was cooled to –78 °C and s-
BuLi (1.3 M in hexanes, 0.39 mL, 0.51 mmol, 1.20 equiv.) was added dropwise. The 
solution was stirred for 3 h at –78 °C, then 7 (125 mg, 0.42 mmol, 1.00 equiv.) was 
Entry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Conditions
Et2O, rt, 12 h
Et2O, reflux, 12 h
MgBr2·Et2O (2.0 equiv.), Et2O, rt, 12 h
MgBr2·Et2O (2.0 equiv.), Et2O, reflux, 12 h
µW, Et2O, 50 °C, 1 h
µW, Et2O, 100 °C, 1 h
12-crown-4 (1.2 equiv.), Et2O, rt, 1 h
then TMSCl (1.2 equiv.), Et2O, rt, 12 h
H2O (0.1 equiv.), Et2O, rt, 1h
then TMSCl (1.2 equiv.), Et2O, rt, 12 h
12-crown-4 (1.2 equiv.), H2O (0.1 equiv.), Et2O, rt, 1 h
then TMSCl (1.2 equiv.), Et2O, rt, 12 h
Solvent exchange to CHCl3, rt, 12 h
Solvent exchange to CHCl3, reflux, 12 h
Solvent exchange to CHCl3, MgBr2·Et2O (2.0 equiv.), reflux, 12 h
Solvent exchange to toluene, rt, 12 h
Solvent exchange to toluene, reflux, 12 h
Yield (%)
–
traces
traces
19%
traces
56%
–
–
–
traces
85%
73%
traces
67%
N
Ph
B(pin)
ABC
D
E F
G
H
J
IBoc
Ph OTIB
8
N B(pin)
Boc 7
N
Boc
Ph
B(pin)
10
(i) s-BuLi, TMEDA
(i) Et2O, –78 °C
(ii)
(ii) CHCl3, reflux
85%
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added, dissolved in Et2O (1 mL). The solution was stirred for 45 min at –78 °C, after 
which 11B NMR analysis of the crude mixture showed complete boronate complex 
formation [11B NMR (92.6 MHz, no solvent) δ = 7].  The solution was warmed to room 
temperature, Et2O was removed under high vacuum and CHCl3 was added. The solution 
was heated under reflux (70 °C) for 12 h. 11B NMR analysis of the crude mixture 
showed full product formation [11B NMR (92.6 MHz, no solvent) δ = 33]. Water (3 mL) 
was added and the layers were separated. The organic layer was washed with Brine 
(2 x 2 mL) and the combined aqueous layers were extracted with CH2Cl2 (3 x 5 mL). 
The organic layers were combined, dried over MgSO4 and concentrated under vacuum. 
The crude product was purified by column chromatography on silica gel, eluting with 
petrol:EtOAc 95:5 to 90:10, to give 10 as a colourless oil (153 mg, 85%). FT-IR νmax 
(film)/cm-1: 2974, 1688, 1388, 1141, 698. 1H NMR (500 MHz, DMSO-d6, 90°C): δ = 
7.28-7.12 (5H, m, HA), 3.84 (1H, m, HB), 3.40 (1H, m, HC), 3.09 (1H, m, HC), 2.62 (1H, 
m, HD), 2.50 (1H, m, HD), 1.94-1.47 (7H, m, HE & HF & HG & HH), 1.36 (9H, s, HI), 
1.22 (12H, s, HJ). 13C NMR (125 MHz, DMSO-d6, 90°C): δ = 154.4 (C=O), 143.0 (C), 
128.6 (2 x CH), 128.5 (2 x CH), 125.9 (CH), 83.2 (2 x C), 78.4 (C), 58.9 & 58.6 (CH), 
47.6 & 46.7 (CH2), 35.8 & 35.4 (CH2), 30.7 & 30.1 (CH2), 27.7 (CH2), 24.0 & 23.6 
(CH2). 11B NMR (96 MHz, CDCl3): δ = 33.  HRMS (ESI) Found: [M+Na]+, 438.2791. 
C24H38BNNaO4 requires [M+Na]+, 438.2790. 
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2.3.  Kinetic studies for 1,2-metallate rearrangement 
 
Preparation of 9: 8 (75 mg, 0.20 mmol, 1.20 equiv.) and TMEDA (0.03 mL, 0.19 
mmol, 1.15 equiv.) we dissolved in Et2O (3 mL). The solution was cooled to –78 °C and 
s-BuLi (1.3 M in hexanes, 0.15 mL, 0.19 mmol, 1.15 equiv.) was added dropwise. The 
solution was stirred for 3 h at –78 °C, then 7 (50 mg, 0.17 mmol, 1.00 equiv.) was 
added, dissolved in Et2O (0.5 mL). The solution was stirred for 45 min at –78 °C, after 
which 11B NMR analysis of the crude mixture showed complete boronate complex 
formation [11B NMR (92.6 MHz, no solvent) δ = 7]. All the volatiles were removed 
under high vacuum to give crude 9 that was used without further purification. 
 
General Procedure for the 11B NMR Kinetic studies – GP 2. 
9 (0.17 mmol) was dissolved in the appropriate solvent (TBME or CDCl3, 0.5 mL) and 
the resulting mixture was stirred for 5 min. The reaction mixture was transferred into a 
quartz NMR tube, immediately placed in a 300 MHz spectrometer pre-equilibrated at 
the desired temperature (24, 29, 35 or 45 °C) and the 11B NMR acquisitions were 
started. The reaction progression was monitored every 30 min following the 
disappearance of 9 [11B NMR (92.6 MHz, no solvent) δ = 7] and the appearance of 10 
[11B NMR (92.6 MHz, no solvent) δ = 33].  
  
Ph OTIB
8
(i) s-BuLi, TMEDA
(i) Et2O, –78 °C
(ii)
N B(pin)
Boc 7
Ph OTIB
9
B(pin)
N
Boc
Li Solvent, T
N
Boc
Ph
B(pin)
10
11B NMR δ 7 ppm 11B NMR δ 33 ppm
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The observed rate constants at each temperature were introduced in the Eyring equation 
to obtain the ΔH‡ and ΔS‡ and entropy of the migration in each solvent: 
 𝑙𝑛 𝑘!"#𝑇 = −∆𝐻!𝑅 ⋅ 1𝑇 + 𝑙𝑛 𝑘!ℎ ⋅ ∆𝑆!𝑅  
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Hence, plotting the logarithm of the quotient between the observed rate constant and the 
corresponding temperature versus the inverse of that temperature, the activation 
enthalpy can be obtained from the slope and the activation entropy from the intercept. 
The following Eyring plots were obtained: 
 
 
 
• TBME: ∆𝐻! = 34± 17 𝑘𝑐𝑎𝑙,∆𝑆! = 0.04± 0.08 𝑘𝑐𝑎𝑙 𝐾 
• CHCl3:  ∆𝐻! = 27± 3 𝑘𝑐𝑎𝑙,∆𝑆! = 0.02± 0.01 𝑘𝑐𝑎𝑙 𝐾 
 
Showing a negligible variation in activation entropy between the two solvents, but a 
change of approximately 7 kcal between the activation entropy in TBME and CHCl3, 
indicating a significant solvent effect for the 1,2-metallate rearrangement.  
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2.4. Stereocontrolled Functionalizations of 7 
 
 
 
(R)-tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolidine-1-
carboxylate [(R)-7] 
 
N-Boc-pyrrolidine (3.00 g, 17.5 mmol, 1.00 equiv.) and (+)-sparteine (4.93 g, 4.80 mL, 
21.0 mmol, 1.20 equiv.) were dissolved in Et2O (180 mL). The solution was cooled to –
78 °C and s-BuLi (1.3 M in hexanes, 16.2 mL, 21.0 mmol, 1.20 equiv.) was added 
dropwise. The solution was stirred for 3 h at –78 °C, then i-PrOB(pin) (4.24 g, 
22.8 mmol, 1.30 equiv.) was added dropwise. The solution was stirred for 1 h at –78 °C, 
then allowed to warm up to room temperature slowly. Aqueous 1 M HCl (150 mL) was 
added and the layers were separated. The organic layers were washed with Brine 
(3 x 50 mL) and the combined aqueous layers were extracted with Et2O (3 x 100 mL). 
The organic layers were combined, dried over MgSO4 and concentrated under vacuum. 
The crude product was purified by fast column chromatography on silica gel, eluting 
with petrol:EtOAc 85:15, to give (R)-7 as a white solid (4.22 g, 81%, 98:2 e.r.). [α]D 
(20 °C, CHCl3, c 1.0) = –60 [lit.[5] for (S)-7, er 95:5, [α]D (20 °C, CHCl3, c 1.0) = 
+50.6]. Other data as above (section 2.1).  
Chiral SFC analysis (Whelk 01 column, 10% IPA/hexane – iso 20%, 4 mL/min, 125 
bar): tR = 3.53 [major, (R)], 4.47 [minor, (S)]. 
N B(pin)
Boc
(R)-7
98:2 er
N
Boc
(S,S)-11
82%
>20:1 dr
99:1 er
OTIB
Li•(–)-sp
N
Boc
(S)-12
79%
97:3 er
N
Boc
(S)-13
81%
98:2 er
LiCl Li
then I2, NaOMe
H
then solvent switch 
to CHCl3
then H2O2/NaOH
Ph OTIB
Li•(+)-sp
Ph
OH
Ph
OH
then solvent switch 
to CHCl3
then H2O2/NaOH
then solvent switch 
to CHCl3
then H2O2/NaOH
(–)-8a
N
Boc
(S,R)-11
77%
>20:1 dr
99:1 er
H
OH
Ph
(+)-8a
N B(pin)
Boc
N
Boc
(i) s-BuLi, (+)-sp
(i) Et2O, –78 °C
(ii) i-PrOB(pin)
81%
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N
Boc
B(pin)
7
N
Boc
B(pin)
(R)-7
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tert-Butyl 2-(1-hydroxy-3-phenylpropyl)pyrrolidine-1-carboxylate (11) 
 
10 (75 mg, 0.18 mmol, 1.0 equiv.) was dissolved in THF (2 mL). The solution was 
cooled to 0 °C and an aqueous solution of 2 M NaOH and 30% H2O2 (2:1 v/v, 6 mL) 
was added dropwise. The solution was stirred vigorously for 2 h at 0 °C, then it was 
warmed to room temperature and diluted with water (10 mL) and EtOAc (10 mL). The 
layers were separated, the organic layer was washed with Brine (2 x 10 mL) and the 
combined aqueous layers were extracted with EtOAc (3 x 10 mL). The organic layers 
were combined, dried over MgSO4 and concentrated under vacuum. The crude product 
was purified by column chromatography on silica gel, eluting with petrol:EtOAc 80:20, 
to give 11 as an oil (53 mg, 96%). See below for spectroscopic data of the pure 
diastereomers. 
Resolution between the enantiomers and diastereomers of 11 was achieved using chiral 
SFC analysis (IC column, 50% IPA/hexane – iso 10%, 3 mL/min, 125 bar). tR = 10.39, 
12.03 ((S,S)-11), 14.47, 17.09 ((S,R)-11). 
 
 
  
(S)-tert-Butyl 2-((R)-1-hydroxy-3-phenylpropyl)pyrrolidine-1-carboxylate 
[(S, R)-11] 
 
8 (200 mg, 0.55 mmol, 1.30 equiv.) and (–)-sparteine (119 mg, 0.12 mL, 0.51 mmol, 
1.20 equiv.) we dissolved in Et2O (5.5 mL). The solution was cooled to –78 °C and s-
BuLi (1.3 M in hexanes, 0.39 mL, 0.51 mmol, 1.20 equiv.) was added dropwise. The 
solution was stirred for 3 h at –78 °C, then 7 (125 mg, 0.42 mmol, 1.00 equiv.) was 
N
Boc
Ph
OH
N
Boc
Ph
B(pin) 10 11
H2O2/NaOH
96%
N
Boc
Ph
OH
11
N
Boc OH
HD
A1
A2 A3
B
C
E
F
GH
I
J
Ph OTIB
8
(i) s-BuLi, (–)-sp
(i) Et2O, –78 °C
(ii)
(ii) CHCl3, reflux
(iii) H2O2/NaOH
N B(pin)
Boc (R)-7
N
Boc OH
Ph
H
(S, R)-11
77%
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added, dissolved in Et2O (1 mL). The solution was stirred for 45 min at –78 °C, after 
which 11B NMR analysis of the crude mixture showed complete boronate complex 
formation [11B NMR (92.6 MHz, no solvent) δ = 7].  The solution was warmed to room 
temperature, Et2O was removed under high vacuum and CHCl3 was added. The solution 
was heated under reflux (70 °C) for 12 h. 11B NMR analysis of the crude mixture 
showed full product formation [11B NMR (92.6 MHz, no solvent) δ = 33]. The solution 
was cooled to room temperature, CHCl3 was removed under high vacuum and THF 
(6 mL) was added. The solution was cooled to 0 °C and an aqueous solution of 2 M 
NaOH and 30% H2O2 (2:1 v/v, 6 mL) was added dropwise. The solution was stirred 
vigorously for 2 h at 0 °C, then it was warmed to room temperature and diluted with 
water (10 mL) and EtOAc (10 mL). The layers were separated, the organic layer was 
washed with Brine (2 x 10 mL) and the combined aqueous layers were extracted with 
EtOAc (3 x 10 mL). The organic layers were combined, dried over MgSO4 and 
concentrated under vacuum. The crude product was purified by column chromatography 
on silica gel, eluting with petrol:EtOAc 80:20, to give (S,R)-11 as an oil (99 mg, 77%, 
99:1 d.r., 99:1 e.r.). [α]D (20 °C, CHCl3, c 1.0) = –36.  FT-IR νmax (film)/cm-1: 3417 
(broad), 2971, 1666, 1396, 1162, 698. 1H NMR (500 MHz, DMSO-d6, 90°C): δ = 7.25 
(2H, t, J 7.4 Hz, HA1), 7.19 (2H, d, J 7.4 Hz, HA2), 7.14 (1H, t, J 7.4 Hz, HA3), 4.38 (1H, 
d, J 5.5 Hz, HB), 3.74 (1H, m, HC), 3.62 (1H, m, HD), 3.36 (1H, dt, J 10.5, 7.4 Hz, HE), 
3.17 (1H, ddd, J 10.5, 7.4, 6.2 Hz, HE), 2.76 (1H, ddd, J 14.0, 8.2, 5.8 Hz, HF), 2.58 
(1H, dt, J 14.0, 8.2 Hz, HF), 1.95 (1H, m, HG), 1.86 (1H, dqnt, J 11.2, 7.8 Hz, HH), 1.73 
(1H, dq, J 11.8, 7.8 Hz, HG), 1.67 (1H, m, HH), 1.60 (2H, m, HI), 1.35 (9H, s, HJ). 13C 
NMR (125 MHz, DMSO-d6, 90 °C): δ = 142.8 (C), 128.7 (2 x CH), 128.5 (2 x CH), 
125.9 (CH), 78.5 (C), 70.6 (CH), 62.1 (CH), 47.1 (CH2), 36.4 (CH2), 32.3 (CH2), 28.7 
(3 x CH3), 25.5 (CH2), 23.4 (CH2), C=O peak not observed. HRMS (ESI) Found: 
[M+Na]+, 328.1885. C18H27NNaO3 requires [M+Na]+, 328.1883. 
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(S)-tert-Butyl 2-((S)-1-hydroxy-3-phenylpropyl)pyrrolidine-1-carboxylate 
[(S,S)- 11] 
 
Following the same experimental procedure described for (S,R)-11 using (+)-sparteine 
as the chiral diamine, (S,S)-11 was obtained as an oil (105 mg, 82%, 99:1 d.r., 99:1 e.r.). 
[α]D (20 °C, CHCl3, c 1.0) = –71.  FT-IR νmax (film)/cm-1: 3377 (broad), 2973, 1663, 
1394, 1161, 699. 1H NMR (500 MHz, DMSO-d6, 90°C): δ = 7.24 (2H, t, J 7.5 Hz, HA1), 
7.18 (2H, d, J 7.5 Hz, HA2), 7.44 (1H, t, J 7.5 Hz, HA3), 4.43 (1H, br d, J 4.4 Hz, HB), 
3.81 (1H, q, J 5.7 Hz, HC), 3.71 (1H, td, J 8.8, 5.7 Hz, HD), 3.39 (1H, dt, J 10.7, 7.6 Hz, 
HE), 3.17 (1H, dt, J 10.7, 6.6 Hz, HE), 2.78 (1H, ddd, J 13.8, 9.4, 5.2 Hz, HF), 2.58 (1H, 
dt, J 13.8, 8.0 Hz, HF), 1.83 (2H, m, HG), 1.78 (1H, m, HH), 1.69 (1H, m, HH), 1.61 (1H, 
m, HI), 1.55 (1H, m, HI), 1.36 (9H, s, HJ). 13C NMR (125 MHz, DMSO-d6, 90°C): δ = 
143.0 (C), 128.7 (2 x CH), 128.5 (2 x CH), 125.9 (CH), 78.8 (C), 71.5 (CH), 61.6 (CH), 
47.5 (CH2), 34.4 (CH2), 32.3 (CH2), 28.7 (3 x CH3), 27.0 (CH2), 24.0 (CH2), C=O peak 
not observed. HRMS (ESI) Found: [M+Na]+, 328.1887. C18H27NNaO3 requires 
[M+Na]+, 328.1883. 
Chiral SFC analysis (IC column, 50% IPA/hexane – iso 10%, 3 mL/min, 125 bar): tR = 
10.39, 12.03 ((S,S)-11), 14.47, 17.09 ((S,R)-11). 
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tert-Butyl 2-(hydroxymethyl)pyrrolidine-1-carboxylate (12) 
 
7 (200 mg, 0.67 mmol, 1.00 equiv.) and BrCH2Cl (261 mg, 0.14 mL, 2.00 mmol, 3.00 
equiv.) were dissolved in Et2O (6 mL). The solution was cooled to −78 °C and n-BuLi 
(1.6 M in hexanes, 1.0 mL, 1.68 mmol, 2.5 equiv.) was added dropwise (very slowly). 
The solution was stirred for 30 min at –78 °C, then it was warmed to room temperature. 
11B NMR analysis of the crude mixture showed complete boronate complex formation 
[11B NMR (92.6 MHz, no solvent) δ = 7]. Et2O was removed under high vacuum and 
CHCl3 was added. The solution was heated under reflux (70 °C) for 20 h. 11B NMR 
analysis of the crude mixture showed full product formation [11B NMR (92.6 MHz, no 
solvent) δ = 33]. The solution was cooled to room temperature, CHCl3 was removed 
under high vacuum and THF (6 mL) was added. The solution was cooled to 0 °C and an 
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aqueous solution of 2 M NaOH and 30% H2O2 (2:1 v/v, 6 mL) was added dropwise. 
The solution was stirred vigorously for 2 h at 0 °C, then it was warmed to room 
temperature and diluted with water (10 mL) and EtOAc (10  mL). The layers were 
separated, the organic layer was washed with Brine (2 x 10 mL) and the combined 
aqueous layers were extracted with EtOAc (3 x 10 mL). The organic layers were 
combined, dried over MgSO4 and concentrated under vacuum. The crude product was 
purified by column chromatography on silica gel, eluting with petrol:EtOAc 80:20 to 
70:30, to give 12 as an oil (70 mg, 52%). 1H NMR (500 MHz, DMSO-d6, 90 °C): δ = 
4.79 (1H, br s), 3.96 (1H, m), 3.60 (2H, m), 3.44 (1H, m), 3.32 (1H, m), 2.00 (1H, m), 
1.88-1.71 (3H, m), 1.46 (9H, s). 13C NMR (125 MHz, DMSO-d6, 90 °C): δ = 80.2 (C), 
67.8 (CH2), 60.2 (CH), 47.5 (CH2), 28.7 (CH2), 28.4 (3 x CH3), 24.0 (CH2), C=O peak 
not observed. Data in accordance with the literature[6]. 
Resolution of the enantiomers of 12 was achieved using chiral SFC analysis after 
derivatisation to 12a (vide infra). 
 
tert-Butyl 2-((benzoyloxy)methyl)pyrrolidine-1-carboxylate (12a) 
 
12 (30 mg, 0.15 mmol, 1.0 equiv.) was dissolved in CH2Cl2:pyridine (2:1 v/v, 1.5 mL). 
The solution was cooled to 0 °C and benzoyl chloride (31 mg, 0.026 mL, 0.22 mmol, 
1.5 equiv.) was added dropwise. The mixture was warmed to room temperature and 
stirred for 6 h. Aqueous NH4Cl (3 mL) was added and the layers were separated. The 
organic layer was washed with Brine (2 x 3 mL) and the combined aqueous layers were 
extracted with CH2Cl2 (3 x 5 mL). The organic layers were combined, dried over 
MgSO4 and concentrated under vacuum. The crude product was purified by column 
chromatography on silica gel, eluting with petrol:EtOAc 97:3 to 95:5, to give 12a as an 
oil (42 mg, 95%). 1H NMR (500 MHz, DMSO-d6, 90 °C): δ = 7.96 (2H, d, J 7.5 Hz), 
7.64 (1H, t, J 7.5 Hz), 7.52 (2H, t, J 7.5 Hz), 4.33 (2H, m), 4.07 (1H, m), 3.36 (1H, m), 
3.27 (1H, m), 2.02 (1H, m), 1.95-1.77 (3H, m), 1.39 (9H, s). 13C NMR (125 MHz, 
DMSO-d6, 90 °C): δ = 166.1 (C=O), 154.1 (C=O), 133.6 (CH), 130.4 (C), 129.6 (2 x 
CH), 129.1 (2 x CH), 79.1 (C), 65.5 (CH2), 55.9 (CH), 46.8 (CH2), 28.6 (3 x CH3), 23.5 
(CH2), 19.3 (CH3). Data in accordance with the literature.[7] 
Resolution of the enantiomers of 12a was achieved using chiral SFC analysis (Whelk-
01 column, 10% IPA/hexane – iso 20%, 4 mL/min, 125 bar). tR = 11.9 min, 15.6 min. 
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(S)-tert-Butyl 2-(hydroxymethyl)pyrrolidine-1-carboxylate [(S)-12] 
 
(R)-7 (200 mg, 0.67 mmol, 1.00 equiv.) and BrCH2Cl (261 mg, 0.14 mL, 2.00 mmol, 
3.00 equiv.) were dissolved in Et2O (6 mL). The solution was cooled to −78 °C and n-
BuLi (1.6 M in hexanes, 1.0 mL, 1.68 mmol, 2.5 equiv.) was added dropwise (very 
slowly). The solution was stirred for 30 min at –78 °C, then it was warmed to room 
temperature. 11B NMR analysis of the crude mixture showed complete boronate 
complex formation [11B NMR (92.6 MHz, no solvent) δ = 7]. Et2O was removed under 
high vacuum and CHCl3 was added. The solution was heated under reflux (70 °C) for 
20 h. 11B NMR analysis of the crude mixture showed full product formation [11B NMR 
(92.6 MHz, no solvent) δ = 33]. The solution was cooled to room temperature, CHCl3 
was removed under high vacuum and THF (6 mL) was added. The solution was cooled 
to 0 °C and an aqueous solution of 2 M NaOH and 30% H2O2 (2:1 v/v, 6 mL) was 
added dropwise. The solution was stirred vigorously for 2 h at 0 °C, then it was warmed 
to room temperature and diluted with water (10 mL) and EtOAc (10  mL). The layers 
were separated, the organic layer was washed with Brine (2 x 10 mL) and the combined 
aqueous layers were extracted with EtOAc (3 x 10 mL). The organic layers were 
combined, dried over MgSO4 and concentrated under vacuum. The crude product was 
purified by column chromatography on silica gel, eluting with petrol:EtOAc 80:20 to 
70:30, to give (S)-12 as an oil (105 mg, 79%, 97:3 e.r., 98% e.s. - determined after 
derivatisation to 12a, vide infra).  [α]D (20 °C, CHCl3, c 1.0) = –35. Other data as 
above. Data in accordance with the literature[6]. 
When the reaction was carried out without solvent exchange (heating to reflux in Et2O 
for 20 h), 12 was obtained in 40% yield (54 mg). 
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(S)-tert-Butyl 2-((benzoyloxy)methyl)pyrrolidine-1-carboxylate [(S)-12a] 
 
(S)-12 (30 mg, 0.15 mmol, 1.0 equiv.) was dissolved in CH2Cl2:pyridine (2:1 v/v, 1.5 
mL). The solution was cooled to 0 °C and benzoyl chloride (31 mg, 0.026 mL, 0.22 
mmol, 1.5 equiv.) was added dropwise. The mixture was warmed to room temperature 
and stirred for 6 h. Aqueous NH4Cl (3 mL) was added and the layers were separated. 
The organic layer was washed with Brine (2 x 3 mL) and the combined aqueous layers 
were extracted with CH2Cl2 (3 x 5 mL). The organic layers were combined, dried over 
MgSO4 and concentrated under vacuum. The crude product was purified by column 
chromatography on silica gel, eluting with petrol:EtOAc 97:3 to 95:5, to give 12a as an 
oil (44 mg, 96%, 97:3 e.r., 98% e.s.). Other data as above. Data in accordance with the 
literature.[7] 
Chiral SFC analysis (Whelk-01 column, 10% IPA/hexane – iso 20%, 4 mL/min, 125 
bar). tR = 11.9 min [(R), minor], 15.6 min [(S), major]. 
 
 
tert-Butyl 2-vinylpyrrolidine-1-carboxylate (13) 
 
n-BuLi (1.6 M in hexanes, 1.26 mL, 2.01 mmol, 3.00 equiv.) was added dropwise to 
neat tetravinyltin (228 mg, 0.18 mL, 1.01 mmol, 1.50 equiv.) at room temperature under 
a N2 atmosphere. The solution was stirred for 30 min, after which the stirring was 
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stopped, the white solid deposited and the colourless solution was decanted. The solid 
was washed with pentane (3 x 1 mL), stirring for 5 minutes and decanting the solution 
after each wash, then it was dissolved in THF (1.5 mL). 7 (200 mg, 0.67 mmol, 
1.00 equiv.) was dissolved in Et2O (5 mL) and cooled to –78 °C. The vinyl lithium 
solution was added dropwise. The solution was stirred for 30 min at –78 °C, then it was 
warmed to –42 °C and stirred for 20 min. 11B crude NMR showed complete boronate 
complex formation [11B NMR (92.6 MHz, no solvent) δ = 7]. The solution was cooled 
to –78 °C and a solution of iodine (533 mg, 2.01 mmol, 3.00 equiv.) in THF (2 mL) was 
added dropwise. The solution was stirred for 15 min at –78 °C, then a suspension of 
MeONa (216 mg, 4.02 mmol, 6.0 equiv.) in MeOH (2 mL) was added. The solution was 
warmed to room temperature and stirred for 1 h. Aqueous Na2S2O3 (10 mL) was added 
and the layers were separated. The organic layer was washed with Brine (2 x 5 mL) and 
the combined aqueous layers were extracted with Et2O (3 x 5 mL). The organic layers 
were combined, dried over MgSO4 and concentrated under vacuum. The crude product 
was purified by column chromatography on silica gel, eluting with petrol:EtOAc 97:3 to 
93:7, to give 13 as a colourless oil (100 mg, 76%). 1H NMR (500 MHz, DMSO-d6, 90 
°C): δ = 5.76 (1H, m), 4.99 (2H, m), 4.19 (1H, m), 3.27 (2H, m), 1.97 (1H, m), 1.76 
(2H, m), 1.65 (1H, m), 1.38 (9H, s). 13C NMR (125 MHz, DMSO-d6, 90 °C): δ = 154.0 
(C=O), 139.8 (CH), 113.7 (CH2), 78.6 (C), 59.0 (CH), 46.5 (CH2), 31.7 (CH2), 28.7 (3 x 
CH3), 23.1 (CH2). Data in accordance with the literature.[6] 
Resolution of the enantiomers of 13 was achieved using chiral GC analysis (Chiraldex 
β-DM column, injector T = 250 °C, detector T = 300 °C, oven conditions: T = 70 °C for 
3 min then ramp (0.5 °C/min) until 110 °C, hold for 5 min then ramp (15 °C/min) until 
180 °C, He carrier gas at 1.0 mL/min, tR (major) = 46.2 min, tR (minor) = 47.9 min, total 
analysis time 93 min). 
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(S)-tert-Butyl 2-vinylpyrrolidine-1-carboxylate [(S)-13] 
 
n-BuLi (1.6 M in hexanes, 1.26 mL, 2.01 mmol, 3.00 equiv.) was added dropwise to 
neat tetravinyltin (228 mg, 0.18 mL, 1.01 mmol, 1.50 equiv.) at room temperature under 
a N2 atmosphere. The solution was stirred for 30 min, after which the stirring was 
stopped, the white solid deposited and the colourless solution was decanted. The solid 
was washed with pentane (3 x 1 mL), stirring for 5 minutes and decanting the solution 
after each wash, then it was dissolved in THF (1.5 mL). (R)-7 (200 mg, 0.67 mmol, 
1.00 equiv.) was dissolved in Et2O (5 mL) and cooled to –78 °C. The vinyl lithium 
solution was added dropwise. The solution was stirred for 30 min at –78 °C, then it was 
warmed to –42 °C and stirred for 20 min. 11B crude NMR showed complete boronate 
complex formation [11B NMR (92.6 MHz, no solvent) δ = 7]. The solution was cooled 
to –78 °C and a solution of iodine (533 mg, 2.01 mmol, 3.00 equiv.) in THF (2 mL) was 
added dropwise. The solution was stirred for 15 min at –78 °C, then a suspension of 
MeONa (216 mg, 4.02 mmol, 6.0 equiv.) in MeOH (2 mL) was added. The solution was 
warmed to room temperature and stirred for 1 h. Aqueous Na2S2O3 (10 mL) was added 
and the layers were separated. The organic layer was washed with Brine (2 x 5 mL) and 
the combined aqueous layers were extracted with Et2O (3 x 5 mL). The organic layers 
were combined, dried over MgSO4 and concentrated under vacuum. The crude product 
was purified by column chromatography on silica gel, eluting with petrol:EtOAc 97:3 to 
93:7, to give (S)-13 as a colourless oil (107 mg, 81%, 98:2 e.r., 100% e.s.). [α]D (20 °C, 
CHCl3, c 1.0) = –6. Other data as above. Data in accordance with the literature.[6] 
Chiral GC analysis (Chiraldex β-DM column, injector T = 250 °C, detector T = 300 °C, 
oven conditions: T = 70 °C for 3 min then ramp (0.5 °C/min) until 110 °C, hold for 5 
min then ramp (15 °C/min) until 180 °C, He carrier gas at 1.0 mL/min, tR (major) = 46.2 
min, tR (minor) = 47.9 min, total analysis time 93 min): 
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2.5. Natural charge (NBO) calculations  
Matteson homologation boron-ate complex 
- Comparison between migrating groups – N-Boc pyrrolidine (I) vs. isopropyl (II) 
 
To further probe the substituent effect on the reactivity, theoretical calculations were 
performed. Molecular mechanics (MM) conformational searches were completed on I 
and II using the default MMFF force field in Spartan ‘14.[8] A number of conformers 
were selected for further geometry optimisation using the GAUSSIAN (version 
GAUSSIAN09)[9] software package and were carried out at the density functional level 
of theory, using the hybrid functional B3LYP.[10] For all elements, the split-valence 
double-zeta polarized basis set 6-31G* was employed. Calculations were performed on 
isolated molecules and NPA charge analysis was carried out by using NBO 3.1.[11] 
Vibrational frequencies were not computed. Results from NPA analysis are shown 
below. Note that only results from the lowest energy conformer are displayed, with 
conformers of higher energy showing negligible deviation in charges. 
 
B3LYP/6-31+G* - NBO Charges 
 C10 B29 C50 Cl53 OBO fragm. CH2Cl fragm. 
Pyrrolidine –0.363 0.949 –0.680 –0.196 –0.154 –0.421 
 C4 B5 C26 Cl29 OBO fragm. CH2Cl fragm. 
Isopropyl –0.594 0.967 –0.680 –0.206 –0.162 –0.429 
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XYZ coordinates for calculated structures discussed 
 
Pyrrolidine (I) 
E = -1468.68539886 H 
 C                  0.49287700    2.60220600    1.49087000 
 H                 -0.26171400    3.09578200    2.12417700 
 H                  1.42153900    2.54519400    2.06755400 
 C                  0.67501700    3.39024000    0.18199600 
 H                  1.61929100    3.09314200   -0.28345700 
 H                  0.67919100    4.47887300    0.32401200 
 C                 -0.50836100    2.93397300   -0.68508500 
 H                 -0.26968500    2.89835900   -1.75438700 
 H                 -1.38225600    3.59285600   -0.57297700 
 C                  0.00103900    1.21185200    1.02176500 
 H                 -0.68014100    0.78417600    1.76300100 
 N                 -0.83113100    1.59860300   -0.16681100 
 C                 -1.97080700    1.01148300   -0.58098900 
 O                 -2.65730800    1.41589100   -1.53027600 
 O                 -2.30103300   -0.05979300    0.19795200 
 C                 -3.36177800   -0.98105500   -0.17587100 
 C                 -3.10164700   -1.58015000   -1.56521400 
 H                 -3.83529700   -2.37179400   -1.76808300 
 H                 -2.09891700   -2.01852700   -1.59906900 
 H                 -3.18016400   -0.81674900   -2.34259000 
 C                 -3.25017100   -2.06950200    0.89916600 
 H                 -3.41025000   -1.64258600    1.89559800 
 H                 -2.25126400   -2.51622700    0.88133900 
 H                 -4.00015900   -2.85223900    0.72745700 
 C                 -4.73011700   -0.28615700   -0.10042800 
 H                 -4.87192200    0.15875800    0.89221300 
 H                 -5.53090600   -1.02002200   -0.26410600 
 H                 -4.80617400    0.50222100   -0.85243300 
 B                  1.22012700    0.11762700    0.75364300 
 O                  2.37920800    0.64516600   -0.05507400 
 O                  0.75699100   -1.05619600   -0.02593600 
 C                  2.50491400   -0.08401900   -1.26658700 
 C                  1.74546700   -1.44092000   -0.96370100 
 C                  1.83855600    0.71534000   -2.40772600 
 H                  2.27927100    1.71957600   -2.43536900 
 H                  0.76420000    0.81903400   -2.23635300 
 H                  1.99354300    0.24820300   -3.39000200 
 C                  3.99807200   -0.24326300   -1.59730500 
 H                  4.54622800   -0.69206300   -0.76393100 
 H                  4.43561300    0.74471900   -1.78985700 
 H                  4.15083100   -0.86201000   -2.49296500 
 C                  1.04677900   -2.06476700   -2.18344200 
 H                  0.55654400   -2.99945200   -1.88276700 
 H                  1.76356300   -2.30065900   -2.98265800 
 H                  0.27900000   -1.39933500   -2.58574700 
 C                  2.66922800   -2.52269500   -0.35346600 
 H                  3.27065200   -2.13128200    0.47044200 
 H                  3.35130500   -2.95059800   -1.10148900 
 H                  2.04117900   -3.32917700    0.04304800 
 C                  1.91343600   -0.26924800    2.21925400 
 H                  2.39699200    0.58850700    2.69863300 
 H                  2.66136300   -1.06017600    2.13224100 
 Cl                 0.75811500   -0.91678200    3.54030900 
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Isopropyl (II) 
E = -1029.37521109 H 
 C                  2.25128600    2.12200100   -0.79645200 
 H                  2.69684400    3.08931300   -0.50402000 
 H                  3.08442400    1.44547300   -1.03651700 
 C                  1.36150000    1.53290300    0.31394300 
 B                  0.52392300    0.19034100   -0.15995600 
 O                 -0.56362400    0.52688600   -1.16518900 
 O                 -0.24571200   -0.37132800    0.99363100 
 C                 -1.83504300    0.40397300   -0.55909900 
 C                 -1.58416400   -0.62351800    0.62202800 
 C                 -2.29205200    1.78986600   -0.04344500 
 H                 -2.24267000    2.50211100   -0.87628100 
 H                 -1.63182700    2.15373900    0.74865500 
 H                 -3.32276100    1.77437600    0.33902000 
 C                 -2.84785400   -0.06937100   -1.61535800 
 H                 -2.50802700   -0.98525900   -2.10739800 
 H                 -2.95729800    0.70267100   -2.38805300 
 H                 -3.83852300   -0.25264100   -1.17487800 
 C                 -2.48059900   -0.41395700    1.85509500 
 H                 -2.23387500   -1.16719400    2.61424700 
 H                 -3.54687800   -0.51670700    1.60714200 
 H                 -2.31594600    0.57145500    2.29998800 
 C                 -1.74045900   -2.09637900    0.17116000 
 H                 -1.18695900   -2.29703000   -0.74990700 
 H                 -2.79231300   -2.37147700    0.00847400 
 H                 -1.33034000   -2.74219000    0.95675400 
 C                  1.41284500   -0.93884000   -0.99432900 
 H                  1.82809300   -0.52670900   -1.92001600 
 H                  0.82040500   -1.81769500   -1.25992100 
 Cl                 2.90696500   -1.68782700   -0.14357300 
 H                  1.67863300    2.28508700   -1.72008200 
 H                  0.58427100    2.28792900    0.52644300 
 C                  2.17214100    1.36231000    1.61290700 
 H                  1.54213000    0.95779600    2.41495000 
 H                  2.59402000    2.32253700    1.96169500 
 H                  3.00966500    0.66737500    1.47398200 
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3. Lithiation-Borylation with Boronic Ester 15 
tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine-1-carboxylate 
(15) 
 
N-Boc-piperidine (14) (2.00 g, 10.8 mmol, 1.00 equiv.) and TMEDA (1.95 mL, 13.0 
mmol, 1.20 equiv.) were dissolved in Et2O (100 mL). The solution was cooled to –78 
°C and s-BuLi (1.3 M in hexanes, 10.0 mL, 13.0 mmol, 1.20 equiv.) was added 
dropwise. The solution was stirred for 3 h at –78 °C, then i-PrOB(pin) (2.61 g, 2.86 mL, 
14.0 mmol, 1.30 equiv.) was added dropwise. The solution was stirred for 1 h at –78 °C, 
then allowed to warm up to room temperature slowly. Aqueous 1 M HCl (150 mL) was 
added and the layers were separated. The organic layers were washed with Brine 
(3 x 50 mL) and the combined aqueous layers were extracted with Et2O (3 x 100 mL). 
The organic layers were combined, dried over MgSO4 and concentrated under vacuum. 
The crude product was purified by fast column chromatography on silica gel, eluting 
with petrol:EtOAc 85:15, to give 15 as an oil (1.89 g, 56%). FT-IR νmax (film)/cm-1: 
2933, 1609, 1370, 1157. 1H NMR (400 MHz, CDCl3): δ = 3.72 (1H, br d, J 12.7, HA), 
2.74 (1H, td, J 12.4, 2.93, HA), 2.30 (1H, dd, J 12.6, 3.2, HB), 1.81 (1H, m, HC), 1.65‐
1.54 (2H, m, HD & HE), 1.49 (9H, s, HF), 1.44 (1H, m, HD), 1.40‐1.29 (2H, m, HC & 
HE), 1.19 (12H, s, HG).	 13C NMR (100 MHz, CHCl3): δ = 139.8 (C=O), 85.6 (2 x C), 
79.9 (C), 42.4 (CH2), 28.4 (3 x CH3), 26.5 (CH2), 25.1 (4 x CH3), 24.9 (CH2), 24.4 
(CH2). 11B NMR (96 MHz, CDCl3): δ = 16. HRMS (ESI) Found: [M+Na]+, 334.2170. 
C20H31NNaO3 requires [M+Na]+, 334.2160. 
 
tert-Butyl 2-(3-phenyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)propyl)piperidine-1-carboxylate (16) 
 
8 (200 mg, 0.55 mmol, 1.30 equiv.) and TMEDA (59 mg, 0.076 mL, 0.51 mmol, 
1.20 equiv.) we dissolved in Et2O (5.5 mL). The solution was cooled to –78 °C and s-
BuLi (1.3 M in hexanes, 0.39 mL, 0.51 mmol, 1.20 equiv.) was added dropwise. The 
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solution was stirred for 3 h at –78 °C, then 15 (131 mg, 0.42 mmol, 1.00 equiv.) was 
added, dissolved in Et2O (1 mL). The solution was stirred for 45 min at –78 °C, after 
which 11B NMR analysis of the crude mixture showed complete boronate complex 
formation [11B NMR (92.6 MHz, no solvent) δ = 7].  The solution was warmed to room 
temperature, Et2O was removed under high vacuum and CHCl3 was added. The solution 
was heated under reflux (70 °C) for 12 h. 11B NMR analysis of the crude mixture 
showed full product formation [11B NMR (92.6 MHz, no solvent) δ = 33]. Water (3 mL) 
was added and the layers were separated. The organic layer was washed with Brine 
(2 x 2 mL) and the combined aqueous layers were extracted with CH2Cl2 (3 x 5 mL). 
The organic layers were combined, dried over MgSO4 and concentrated under vacuum. 
The crude product was purified by column chromatography on silica gel, eluting with 
petrol:EtOAc 95:5 to 90:10, to give 16 as a colourless oil (150 mg, 83%). FT-IR νmax 
(film)/cm-1: 2930, 1685, 1414, 1253, 1160, 1029, 698. 1H NMR (500 MHz, DMSO-d6, 
90°C): δ = 7.27-7.09 (5H, m, HA), 4.22 (1H, app. d, J 11.6 Hz, HB), 3.78 (1H, app. d, 
J 13.1 Hz, HC), 2.64 (1H, m, HD), 2.55 (1H, app. t, J 13.1 Hz, HC), 2.44 (1H, m, HD), 
1.65-1.41 (8H, m, HE & HF & HG & HH), 1.35 (9H, s, HI), 1.24 (12H, s, HJ), 1.18 (1H, 
m, HK). 13C NMR (125 MHz, DMSO-d6, 90°C): δ = 154.8 (C=O), 142.9 (C), 128.6 (2 x 
CH), 128.4 (2 x CH), 125.9 (CH), 83.5 (2 x C), 78.6 (C), 51.7 (CH), 38.5 (CH2), 34.9 
(CH2), 30.2 (CH2), 29.6 (CH2), 28.7 (3 x CH3), 25.6 (CH2), 25.1 (4 x CH3), 19.2 (CH2). 
11B NMR (96 MHz, CDCl3): δ = 33.  HRMS (ESI) Found: [M+Na]+, 452.2941. 
C25H40BNNaO4 requires [M+Na]+, 452.2947. 
	 SI-30 
4. Synthesis of Building Block 6 
 
 
(R)-4-((tert-Butyldiphenylsilyl)oxy)-2-methylbutan-1-ol (28) 
 
Following a literature procedure[12], a solution of (R)-2-methylbutane-1,4-diol (14) (500 
mg, 0.51 mL, 4.80 mmol, 1.00 equiv.) in dry DMF (20 mL) was cooled to –42 °C. DBU 
(1.10 g, 1.08 mL, 7.20 mmol, 1.50 equiv.) was added, followed by a slow dropwise 
addition of tert-butyldiphenylsilyl chloride (1.39 g, 1.29 mL, 5.04 mmol, 1.05 equiv.). 
The solution was stirred for 8 h at –42 °C, then aqueous NaHCO3 (20 mL) was added. 
The solution was diluted with Et2O and the layers were separated. The organic layer 
was washed with Brine (10 mL) and the combined aqueous layers were extracted with 
Et2O (3 x 10 mL). The organic layers were combined, dried over MgSO4 and 
concentrated under vacuum. The crude product was purified by column chromatography 
on silica gel, eluting with petrol:EtOAc 90:10 to 80:20, to give 28 as a colourless oil 
(1.42 g, 86%). 1H NMR (400 MHz, CDCl3): δ = 7.70-7.65 (4H, m), 7.47-7.36 (6H, m), 
3.80-3.65 (2H, m), 3.54-3.44 (2H, m), 1.90-1.79 (1H, m), 1.69-1.58 (1H, m), 1.54-1.44 
(1H, m), 1.05 (9H, s), 0.90 (3H, d, J = 6.5 Hz). 13C NMR (100 MHz, CDCl3): δ = 135.6 
(4 x CH), 133.4 (2 x C), 129.6 (2 x CH), 127.7 (4 x CH), 68.3 (CH2), 63.8 (CH2), 36.7 
(CH2), 33.9 (CH), 26.8 (3 x CH3), 19.1 (C), 17.2 (CH3). Data in accordance with the 
literature[12].  
 
(R)-4-((Tert-butyldiphenylsilyl)oxy)-2-methylbutyl 2,4,6-triisopropylbenzoate (6) 
 
To a solution of 28 (1.24 g, 3.6 mmol, 1.1 equiv.) in THF (15 mL, 0.25 M) were added 
Ph3P (944 mg, 3.6 mmol, 1.1 equiv.) and 2,4,6-triisopropylbenzoic acid (813 mg, 3.3 
mmol, 1.0 equiv.). The mixture was cooled to 0 °C, then diisopropylacadicarboxylate 
(729 mg, 0.71 mL, 3.6 mmol, 1.1 equiv.) was added dropwise. The solution was stirred 
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for 30 min at 0 °C, hen it was warmed to room temperature and stirred for 4 h. Saturated 
NH4Cl (10 mL) was added and the layers were separated. The organic layer was washed 
with Brine (2 x 10 mL) and the combined aqueous layers were extracted with Et2O (3 x 
10 mL). The organic layers were combined, dried over MgSO4 and concentrated under 
vacuum. The crude product was triturated with petrol, then it was purified by column 
chromatography on silica gel, eluting with petrol:EtOAc 99:1 to 97:3, to give 6 as a 
colourless oil (1.70 g, 90%). [α]D (20 °C, CHCl3, c 1.0) = –3. FT-IR νmax (film)/cm-1: 
2960, 1724, 1461, 1249, 1104, 1074, 700. 1H NMR (400 MHz, CDCl3): δ = 7.69-7.63 
(4H, m, HA), 7.45-7.33 (6H, m, HB & HC), 7.00 (2H, s, HD), 4.22 (1H, dd, J = 10.9, 5.5 
Hz, HE), 4.11 (1H, dd, J = 10.9, 6.7 Hz, HE), 3.73 (2H, m, HF), 2.90 (1H, sept, J = 6.8 
Hz, HG), 2.85 (2H, sept, J = 6.8 Hz, HH), 2.14 (1H, m, HI), 1.76 (1H, m, HJ), 1.44 (1H, 
m, HJ), 1.26 (6H, d, J = 6.8 Hz, HK), 1.24 (12H, d, J = 6.8 Hz, HL), 1.05 (9H, s, HM), 
0.97 (3H, d, J = 6.4 Hz, HN). 13C NMR (100 MHz, CDCl3): δ = 171.2 (C=O), 150.0 
(C), 144.7 (2 x C), 135.5 (4 x CH), 133.8 (2 x C), 130.7 (C), 129.6 (2 x CH), 127.6 (4 x 
CH), 120.8 (2 x CH), 70.0 (CH2), 61.5 (CH2), 36.0 (CH2), 34.4 (CH), 31.5 (2 x CH), 
29.3 (CH), 26.8 (3 x CH3), 24.2 (2 x CH3), 23.9 (4 x CH3), 19.2 (C), 16.9 (CH3). 
HRMS (ESI) Found: [M+Na]+, 595.3596. C37H52NaO3Si requires [M+Na]+, 595.3578. 
  
	 SI-32 
4. Synthesis of 5 via Lithiation-Borylation-Zweifel Olefination 
 
tert-Butyl (S)-2-((1R,2R)-4-((tert-butyldiphenylsilyl)oxy)-2-methyl-1-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)butyl)pyrrolidine-1-carboxylate (18) 
 
6 (100 mg, 0.17 mmol, 1.30 equiv.) and (–)-sparteine (37.5 mg, 0.037 mL, 0.16 mmol, 
1.20 equiv.) were dissolved in Et2O (2 mL, 0.1 M). The solution was cooled to –78 °C 
and s-BuLi (1.3 M in hexanes, 0.12 mL, 0.16 mmol, 1.20 equiv.) was added dropwise. 
The solution was stirred for 3 h 30 min at –78 °C, then (R)-7 (40 mg, 0.13 mmol, 
1.00 equiv.) was added, dissolved in Et2O (0.5 mL). The solution was stirred for 45 min 
at –78 °C, after which 11B NMR analysis of the crude mixture showed complete 
boronate complex formation [11B NMR (92.6 MHz, no solvent) δ = 7].  The solution 
was warmed to room temperature, Et2O was removed under high vacuum and CHCl3 
was added. The solution was heated under reflux (70 °C) for 36 h. 11B NMR analysis of 
the crude mixture showed full product formation [11B NMR (92.6 MHz, no solvent) 
δ = 33]. Water (3 mL) was added and the layers were separated. The organic layer was 
washed with Brine (2 x 2 mL) and the combined aqueous layers were extracted with 
CH2Cl2 (3 x 5 mL). The organic layers were combined, dried over MgSO4 and 
concentrated under vacuum. The crude product was purified by column chromatography 
on silica gel, eluting with petrol:EtOAc 97:3 to 90:10, to give 18 as a colourless oil (47 
mg, 58%, 96:4 d.r.). [α]D (20 °C, CHCl3, c 1.0) = –27. FT-IR νmax (film)/cm-1: 2930, 
1690, 1388, 1106, 701. 1H NMR (500 MHz, DMSO-d6, 90°C): δ = 7.62 (4H, m, HA), 
7.42 (6H, m, HB & HB1), 3.85 (1H, m, HC), 3.71 (2H, m, HD), 3.44 (1H, m, HE), 3.08 
(1H, m, HF), 1.93-1.56 (7H, m, HG & HH & HI & HJ & HK), 1.39 (9H, s, HL), 1.32 (1H, 
m, HM), 1.19 (6H, s, HN), 1.17 (6H, s, HN’), 1.02 (9H, s, HO), 0.84 (3H, d, J 6.5 Hz, HP). 
13C NMR (125 MHz, DMSO-d6, 90 °C): δ = 155.4 (C=O), 135.4 (4 x CH), 134.3 (2 x 
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C), 130.2 (2 x CH), 128.1 (4 x CH), 83.0 (2 x C), 78.4 (C), 62.7 (CH2), 57.5 (CH), 46.8 
(CH2), 39.4 (CH2), 35.4 (CH), 29.6 (CH2), 29.3 (CH), 28.7 (3 x CH3), 27.3 (3 x CH3), 
25.2 (2 x CH3), 25.1 (2 x CH3), 23.9 (CH2), 19.7 (CH3), 19.2 (C). 11B NMR (96 MHz, 
CDCl3): δ = 33. HRMS (ESI) Found: [M+Na]+, 644.3893, [M+H]+, 622.4076. 
C36H56NaBNO5Si requires [M+Na]+, 644.3893, C36H56BNO5Si requires [M+H]+, 
622.4100. 
 
 (2S)-tert-Butyl 2-((2R)-4-((tert-butyldiphenylsilyl)oxy)-2-methyl-1-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)butyl)pyrrolidine-1-carboxylate (18b) 
 
6 (150 mg, 0.26 mmol, 1.30 equiv.) and TMEDA (0.035 mL, 0.24 mmol, 1.20 equiv.) 
were dissolved in Et2O (2 mL, 0.1 M). The solution was cooled to –78 °C and s-BuLi 
(1.3 M in hexanes, 0.18 mL, 0.24 mmol, 1.20 equiv.) was added dropwise. The solution 
was stirred for 3 h 30 min at –78 °C, then (R)-7 (60 mg, 0.20 mmol, 1.00 equiv.) was 
added, dissolved in Et2O (0.5 mL). The solution was stirred for 45 min at –78 °C, after 
which 11B NMR analysis of the crude mixture showed complete boronate complex 
formation [11B NMR (92.6 MHz, no solvent) δ = 7].  The solution was warmed to room 
temperature, Et2O was removed under high vacuum and CHCl3 was added. The solution 
was heated under reflux (70 °C) for 36 h. 11B NMR analysis of the crude mixture 
showed full product formation [11B NMR (92.6 MHz, no solvent) δ = 33]. Water (3 mL) 
was added and the layers were separated. The organic layer was washed with Brine (2 x 
2 mL) and the combined aqueous layers were extracted with CH2Cl2 (3 x 5 mL). The 
organic layers were combined, dried over MgSO4 and concentrated under vacuum. The 
crude product was purified by column chromatography on silica gel, eluting with 
petrol:EtOAc 97:3 to 90:10, to give 18b as a colourless oil (78 mg, 63%). 
Characterisation data as above. 
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tert-Butyl 2-((2R)-4-((tert-butyldiphenylsilyl)oxy)-2-methyl-1-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)butyl)pyrrolidine-1-carboxylate (18a) 
 
6 (100 mg, 0.26 mmol, 1.30 equiv.) and TMEDA (0.037 mL, 0.24 mmol, 1.20 equiv.) 
were dissolved in Et2O (2 mL, 0.1 M). The solution was cooled to –78 °C and s-BuLi 
(1.3 M in hexanes, 0.18 mL, 0.24 mmol, 1.20 equiv.) was added dropwise. The solution 
was stirred for 3 h 30 min at –78 °C, then 7 (60 mg, 0.20 mmol, 1.00 equiv.) was added, 
dissolved in Et2O (0.5 mL). The solution was stirred for 45 min at –78 °C, after which 
11B NMR analysis of the crude mixture showed complete boronate complex formation 
[11B NMR (92.6 MHz, no solvent) δ = 7].  The solution was warmed to room 
temperature, Et2O was removed under high vacuum and CHCl3 was added. The solution 
was heated under reflux (70 °C) for 36 h. 11B NMR analysis of the crude mixture 
showed full product formation [11B NMR (92.6 MHz, no solvent) δ = 33]. Water (3 mL) 
was added and the layers were separated. The organic layer was washed with Brine (2 x 
2 mL) and the combined aqueous layers were extracted with CH2Cl2 (3 x 5 mL). The 
organic layers were combined, dried over MgSO4 and concentrated under vacuum. The 
crude product was purified by column chromatography on silica gel, eluting with 
petrol:EtOAc 97:3 to 90:10, to give 18 as a colourless oil (72 mg, 58%). 
Characterisation data as above. 
 
Resolution between the diastereomers in 18a and 18b was achieved using chiral SFC 
analysis (Whelk-01 column, 10% IPA/Hexane – iso 20%, 4 mL/min, 125 bar). tR 7.29, 
8.28, 8.77, 10.96 (major, 18). 
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tert-Butyl (S)-2-((3R,4R)-6-((tert-butyldiphenylsilyl)oxy)-4-methylhex-1-en-3-
yl)pyrrolidine-1-carboxylate (5) 
 
n-BuLi (1.6 M in hexanes, 1.55 mL, 2.48 mmol, 5.00 equiv.) was added dropwise to 
neat tetravinyltin (280 mg, 0.23 mL, 1.24 mmol, 2.50 equiv.) at room temperature under 
a N2 atmosphere. The solution was stirred for 30 min, after which the stirring was 
stopped, the white solid deposited and the colourless solution was decanted. The solid 
was washed with pentane (3 x 1 mL), stirring for 5 minutes and decanting the solution 
after each wash, then it was dissolved in THF (1.5 mL). 15 (308 mg, 0.50 mmol, 
1.00 equiv.) was dissolved in Et2O (5 mL) and cooled to –78 °C. The vinyl lithium 
solution was added dropwise. The solution was stirred for 30 min at –78 °C, then it was 
warmed to –42 °C and stirred for 20 min. 11B crude NMR showed complete boronate 
complex formation [11B NMR (92.6 MHz, no solvent) δ = 7]. The solution was cooled 
to –78 °C and a solution of iodine (630 mg, 2.48 mmol, 5.00 equiv.) in THF (4 mL) was 
added dropwise. The solution was stirred for 15 min at –78 °C, then a suspension of 
MeONa (268 mg, 4.96 mmol, 10.0 equiv.) in MeOH (2 mL) was added. The solution 
was warmed to room temperature and stirred for 1 h. Aqueous Na2S2O3 (10 mL) was 
added and the layers were separated. The organic layer was washed with Brine 
(2 x 5 mL) and the combined aqueous layers were extracted with Et2O (3 x 5 mL). The 
organic layers were combined, dried over MgSO4 and concentrated under vacuum. The 
crude product was purified by column chromatography on silica gel, eluting with 
petrol:EtOAc 97:3 to 95:5, to give 5 as a colourless oil (185 mg, 71%). [α]D (20 °C, 
CHCl3, c 1.0) = –47. FT-IR νmax (film)/cm-1: 2930, 1690, 1456, 1389, 1105, 700. 
1H NMR (500 MHz, DMSO-d6, 90°C): δ = 7.62 (4H, m, HA), 7.42 (6H, m, HB & HB1), 
5.60 (1H, dt, J 10.5, 1.2 Hz, HC), 5.05 (1H, dd, J 10.5, 2.5 Hz, HD), 4.90 (1H, dd, J 17.2, 
2.5 Hz, HE), 3.92 (1H, m, HF), 3.71 (2H, m, HG), 3.36 (1H, m, HH), 3.04 (1H, m, HI), 
2.38 (1H, m, HJ), 1.87-1.56 (6H, m, HK & HL & HM & HN), 1.39 (9H, s, HO), 1.23 (1H, 
m, HP), 1.02 (9H, s, HQ), 0.86 (3H d, J 6.4 Hz, HR). 13C NMR (125 MHz, DMSO-d6, 90 
°C): δ = 153.9 (C=O), 138.1 (CH), 135.5 (4 x CH), 134.1 (2 x C), 130.1 (2 x CH), 128.1 
(4 x CH), 118.0 (CH2), 78.5 (C), 62.4 (CH2), 58.7 (CH), 51.8 (CH), 46.9 (CH2), 37.4 
(CH2), 30.8 (CH), 28.7 (3 x CH3), 27.3 (3 x CH3), 26.4 (CH2), 23.8 (CH2), 19.2 (C), 
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17.9 (CH3). HRMS (ESI) Found: [M+Na]+, 544.3209, [M+H]+, 522.3391. 
C32H47NaNO3Si requires [M+Na]+, 544.3217, C32H47NO3Si requires [M+H]+, 522.3398. 
 
One-pot lithiation-borylation-Zweifel olefination procedure from 6 and 7 to 5: 
6 (2.52 g, 4.40 mmol, 1.00 equiv.) and (–)-sparteine (1.24 g, 1.20 mL, 5.30 mmol, 
1.20 equiv.) were dissolved in Et2O (45 mL). The mixture was cooled to –78 °C and s-
BuLi (1.3 M in hexanes, 4.08 mL, 5.30 mmol, 1.20 equiv.) was added. The mixture was 
stirred for 4 h at –78 °C, then 7 (1.58 g, 5.30 mmol, 1.20 equiv.) in Et2O (5 mL) was 
added. The solution was stirred for 45 min at –78 °C, after which crude 11B NMR 
showed complete boronate complex formation [11B NMR (92.6 MHz, no solvent) 
δ = 7].  The solution was warmed to room temperature, Et2O was removed under high 
vacuum and CHCl3 (45 mL) was added. The solution was heated under reflux (70 °C) 
for 36 h. Crude 11B NMR showed full product formation [11B NMR (92.6 MHz, no 
solvent) δ = 33]. CHCl3 was removed under vacuum and Et2O (45 mL) was added. The 
mixture was cooled to –78 °C and a freshly prepared solution of vinyl lithium (from 
tetravinyl tin 2.5 g, 2.0 mL, 11 mmol, 2.5 equiv, and n-BuLi, 1.6 M in hexanes, 
13.75 mL, 22 mmol, 5.0 equiv.) in THF (20 mL) was added. The solution was stirred 
for 30 min at –78 °C, then it was warmed to –42 °C and stirred for 20 min. 11B crude 
NMR showed complete boronate complex formation [11B NMR (92.6 MHz, no solvent) 
δ = 7]. The solution was cooled to –78 °C and a solution of iodine (5.60 g, 22.0 mmol, 
5.00 equiv.) in THF (15 mL) was added dropwise. The solution was stirred for 15 min 
at –78 °C, then a suspension of MeONa (2.38 mg, 44.0 mmol, 10.0 equiv.) in MeOH 
(10 mL) was added. The solution was warmed to room temperature and stirred for 1 h. 
Aqueous Na2S2O3 (70 mL) was added and the layers were separated. The organic layer 
was washed with Brine (2 x 30 mL) and the combined aqueous layers were extracted 
with Et2O (3 x 30 mL). The organic layers were combined, dried over MgSO4 and 
concentrated under vacuum. The crude product was purified by column chromatography 
on silica gel, eluting with petrol:EtOAc 97:3 to 95:5, to give 5 as a colourless oil (1.6 g, 
70%). Data as above. 
  
	 SI-38 
5. Synthesis of 20 
 
 
tert-Butyl (S)-2-((3R,4R)-6-hydroxy-4-methylhex-1-en-3-yl)pyrrolidine-1-
carboxylate (29) 
 
To a solution of 5 (970 mg, 1.86 mmol, 1.00 equiv.) in THF (20 mL) was added 
tetrabutylammonium fluoride (1.00 M in THF, 3.70 mL, 3.71 mmol, 2.00 equiv.) 
dropwise at 0 °C. The solution was stirred for 16 h warming to room temperature. 
Aqueous NH4Cl (20 mL) was added and the layers were separated. The organic layer 
was washed with Brine (2 x 10 mL) and the combined aqueous layers were extracted 
with Et2O (3 x 10 mL). The organic layers were combined, dried over MgSO4 and 
concentrated under vacuum. The crude product was purified by column chromatography 
on silica gel, eluting with petrol: EtOAc 80:20 to 75:25, to give 29 as a colourless oil 
(525 mg, 98%). [α]D (20 °C, CHCl3, c 1.0) = –2. FT-IR νmax (film)/cm-1: 3410 (broad), 
2925, 1693, 1392, 1168. 1H NMR (500 MHz, DMSO-d6, 90 °C): δ = 5.64 (1H, dt, J 
17.0, 9.7 Hz, HA), 5.07 (1H, dd, J 9.7, 2.0 Hz, HB), 4.92 (1H, dd, J 17.0, 2.0 Hz, HC), 
3.95 (1H, m, HD), 3.51-3.34 (3H, m, HE & HF), 3.05 (1H, m, HG), 2.39 (1H, m, HH), 
1.90-1.62 (5H, m, HI & HJ & HK), 1.57 (1H, m, HL), 1.42 (9H, s, HM), 1.11 (1H, m, 
HN), 0.91 (3H, d, J 7.7 Hz, HO). 13C NMR (125 MHz, DMSO-d6, 90 °C): δ = 154.0 
(C=O), 138.4 (CH), 117.8 (CH2), 78.5 (C), 59.5 (CH2), 58.7 (CH), 52.1 (CH), 46.9 
(CH2), 37.8 (CH2), 30.9 (CH), 28.8 (3 x CH3), 26.5 (CH2), 23.9 (CH2), 18.0 (CH3). 
HRMS (ESI) Found: [M+Na]+, 306.2028, [M+H]+, 284.2211. C16H29NaNO3 requires 
[M+Na]+, 306.2040, C16H29NO3 requires [M+H]+, 284.2220. 
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tert-Butyl (S)-2-((3R,4R)-4-methyl-6-((2,4,6-triisopropylbenzoyl)oxy)hex-1-en-3-
yl)pyrrolidine-1-carboxylate (19) 
 
To a solution of 29 (431 mg, 1.52 mmol, 1.10 equiv.) in THF (0.25 M, 6 mL) were 
added triphenylphosphine (400 mg, 1.52 mmol, 1.10 equiv.) and triisopropylbenzoic 
acid (343 mg, 1.38 mmol, 1.00 equiv.). The solution was cooled to 0 °C and 
diisopropylazadicarbozylate (307 mg, 0.30 mL, 1.52 mmol, 1.10 equiv.) was added 
dropwise. The solution was stirred for 30 min at 0 °C, then it was warmed to room 
temperature and stirred for another 4 h. Aqueous NH4Cl (10 mL) was added and the 
layers were separated. The organic layer was washed with Brine (2 x 5 mL) and the 
combined aqueous layers were extracted with Et2O (3 x 10 mL). The organic layers 
were combined, dried over MgSO4 and concentrated under vacuum. The crude product 
was purified by column chromatography on silica gel, eluting with petrol:EtOAc 95:5 to 
90:10, to give 19 as an oil (685 mg, 96%). [α]D (20 °C, CHCl3, c 1.0) = –50. FT-IR 
νmax (film)/cm-1: 2962, 1722, 1681,, 1460, 1391, 1250, 753. 1H NMR (500 MHz, 
DMSO-d6, 90°C): δ = 7.05 (2H, s, HA), 5.65 (1H, dt, J 16.8, 9.9 Hz, HB), 5.09 (1H, dd, 
J 9.9, 1.8 Hz, HC), 4.96 (1H, dd, J 16.8, 1.8 Hz, HD), 4.30 (2H, m, HE), 3.96 (1H, m, 
HF), 3.38 (1H, m, HG), 3.06 (1H, m, HG), 2.90 (1H, sept, J 6.7 Hz, HH), 2.80 (2H, sept, J 
6.7 Hz, HI), 2.43 (1H, m, HJ), 1.97 (1H, m, HK), 1.85 (1H, m, HL), 1.80-1.57 (4H, m, HL 
& HM & HN), 1.41 (9H, s, HO), 1.36 (1H, m, HK), 1.22 (6H, d, J 6.7 Hz, HP), 1.19 (12 H, 
d, J 6.7 Hz, HQ), 0.98 (3H, d, J 7.0 Hz, HR). 13C NMR (125 MHz, DMSO-d6, 90 °C): δ 
= 170.3 (C=O), 154.0 (C=O), 150.2 (C), 144.8 (2 x C), 137.8 (CH), 121.0 (2 x CH), 
118.2 (CH2), 78.6 (C), 63.5 (CH2), 58.5 (CH), 51.6 (CH), 46.9 (CH2), 34.0 (CH), 33.4 
(CH2), 31.3 (2 x CH), 31.1 (CH), 28.7 (3 x CH3), 26.6 (CH2), 24.2 (4 x CH3), 24.1 (2 x 
CH3), 23.8 (CH2), 17.6 (CH3). HRMS (ESI) Found: [M+Na]+, 536.3710, [M+H]+, 
514.3892. C32H51NaNO4 requires [M+Na]+, 336.3710, C32H52NO4 requires [M+H]+, 
514.3891. 
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(3R,4R)-3-Methyl-4-((S)-pyrrolidin-2-yl)hex-5-en-1-yl 2,4,6-triisopropylbenzoate 
(30) 
 
To a solution of 19 (835 mg, 1.62 mmol, 1.00 equiv.) in CH2Cl2 (15 mL) was added 
dropwise TFA (1.24 mL, 16.2 mmol, 10.0 equiv.) at room temperature. The solution 
was stirred for 90 min, then water (15 mL) was added. The biphasic solution was cooled 
to 0 °C and NH4OH was added until the pH of the aqueous layer was basic. The layers 
were separated and the aqueous layer was extracted with CH2Cl2:MeOH:NH4OH 
89.9:10:0.1 (4 x 10 mL). The organic layers were combined, dried over MgSO4 and 
concentrated under vacuum, to give 30 as an oil, which was used in the following step 
without further purification (670 mg, quantitative crude yield). [α]D (20 °C, CHCl3, c 
1.0) = –13. FT-IR νmax (film)/cm-1: 2960, 1721, 1606, 1460, 1250, 1076, 737. 1H NMR 
(400 MHz, CDCl3): δ = 6.98 (2H, s, HA), 5.53 (1H, dt, J 17.0, 10.1 Hz, HB), 5.15 (1H, 
dd, J 10.1, 2.1 Hz, HC), 5.09 (1H, dd, J 17.0, 2.1 Hz, HD), 4.38 (1H, ddd, J 11.0, 8.0, 5.0 
Hz, HE), 4.27 (1H, dt, J 11.0, 7.7 Hz, HE), 3.16 (1H, m, HF), 3.01 (1H, dt, J 11.1, 6.5 
Hz, HG), 2.93-2.76 (4H, m, HG & HH & HI), 2.03 (1H, m, HJ), 1.97 (1H, m, HK), 1.81 
(1H, m, HK), 1.76-1.65 (3H, m, HL & HM), 1.36 (2H, m, HN), 1.22 (18H, d, J 6.9 Hz, 
HO), 0.98 (3H, d, J 6.6 Hz, HP). 13C NMR (100 MHz, CDCl3): δ = 171.1 (C=O), 150.2 
(C), 144.8 (2 x C), 136.1 (CH), 130.7 (C), 120.9 (2 x CH), 119.2 (CH2), 63.7 (CH2), 
59.5 (CH), 54.6 (CH), 46.4 (CH2), 34.5 (CH2), 31.6 (CH), 31.5 (2 x CH), 31.4 (CH2), 
28.6 (CH), 25.3 (CH2), 24.2 (4 x CH3), 24.0 (2 x CH3), 17.9 (CH3). HRMS (ESI) 
Found: [M+H]+, 414.3385. C27H44NO2 requires [M+H]+, 414.3367. 
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(3R,4R)-4-((S)-1-(but-3-en-1-yl)pyrrolidin-2-yl)-3-methylhex-5-en-1-yl 2,4,6-
triisopropylbenzoate (20) 
 
To a solution of 30 (670 mg, 1.62 mmol, 1.00 equiv.) in toluene (0.3 M, 5.5 mL) was 
added K2CO3 (448 mg, 3.24 mmol, 2.00 equiv.). The solution was cooled to 0 °C and 4-
bromo-1-butene (0.25 mL, 2.43 mmol, 1.50 equiv.) was added dropwise, followed by 
addition of KI (54 mg, 0.32 mmol, 0.20 equiv.) and DMF (0.2 mL). The solution was 
heated to reflux and stirred for 72 h. Water (5 mL) was added and the layers were 
separated. The organic layer was washed with Brine (2 x 5 mL) and the combined 
aqueous layers were extracted with EtOAc (3 x 5 mL). The organic layers were 
combined, dried over MgSO4 and concentrated under vacuum. The crude product was 
purified by column chromatography on silica gel, eluting with CH2Cl2:MeOH:NH4OH 
99.5:0:0.5 to 96.5:3:0.5, to give 20 as an oil (663 mg, 87%). [α]D (20 °C, CHCl3, c 1.0) 
= –47. FT-IR νmax (film)/cm-1: 2960, 1723, 1460, 1250, 1074, 909, 756. 1H NMR (500 
MHz, CDCl3): δ = 7.02 (2H, s, HA), 5.80 (1H, m, HB), 5.68 (1H, dt, J 17.0, 9.9 Hz, HC), 
5.18-4.97 (4H, m, HD & HE), 4.41 (1H, ddd, J 11.0, 7.9, 5.0 Hz, HF), 4.31 (1H, dt, J 
11.0, 7.6 Hz, HF), 3.19 (1H, m, HG), 2.95-2.79 (4H, m, HG & HH & HI), 2.47 (1H, m, 
HJ), 2.24 (2H, m, HK), 2.14-2.00 (4H, m, HL & HM & HN), 1.77-1.64 (5H, m, HO & HP 
& HQ), 1.40 (1H, m, HN), 1.26 (6H, d, J 6.7 Hz, HR), 1.25 (12H, d, J 6.7 Hz, HR’), 1.02 
(3H, d, J 6.8 Hz, HS). 13C NMR (125 MHz, CDCl3): δ = 171.0 (C=O), 150.1 (C), 144.7 
(2 x C), 137.1 (CH), 136.8 (CH), 130.7 (C), 120.8 (2 x CH), 117.2 (CH2), 115.3 (CH2), 
65.2 (CH), 63.3 (CH2), 53.8 (CH2), 53.7 (CH2), 51.3 (CH), 34.4 (CH), 33.3 (CH2), 32.9 
(CH2), 31.5 (2 x CH), 30.9 (CH), 25.5 (CH2), 24.2 (4 x CH3), 24.1 (2 x CH3), 22.2 
(CH2), 17.6 (CH3). HRMS (ESI) Found: [M+H]+, 468.3829. C31H50NO2 requires 
[M+H]+, 468.3836. 
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6. Synthesis of 3 
 
 
(R)-3-((9S,9aS)-2,3,5,6,9,9a-Hexahydro-1H-pyrrolo[1,2-a]azepin-9-yl)butyl 2,4,6-
triisopropylbenzoate (31) 
 
20 (350 mg, 0.75 mmol, 1.00 equiv.) was dissolved in toluene (0.01 M, 75 mL). The 
solution was degassed, then camphorsulfonic acid (184 mg, 0.79 mmol, 1.05 equiv.) 
was added. The solution was stirred for 20 min, then Hoveyda-Grubbs 2nd Generation 
catalyst (94 mg, 0.15 mmol, 0.20 equiv.) was added. The solution was heated to 80 °C 
and stirred at that temperature for 5 h. Ethyl vinyl ether (0.2 mL) was added, followed 
by water (50 mL) and NH4OH, until the aqueous layer reached basic pH. The layers 
were separated, the organic layer was washed with Brine (2 x 20 mL) and the combined 
aqueous layers were extracted with EtOAc (3 x 30 mL). The organic layers were 
combined, dried over MgSO4 and concentrated under vacuum. The crude product was 
purified by column chromatography on silica gel, eluting with CH2Cl2:MeOH:NH4OH 
99.5:0:0.5 to 94.5:5:0.5, to give 31 as an oil (275 mg, 84%). [α]D (20 °C, CHCl3, c 1.0) 
= +42. FT-IR νmax (film)/cm-1: 2960, 1721, 1460, 1250, 1075, 908, 731. 1H NMR (500 
MHz, CDCl3): δ = 7.03 (2H, s, HA), 5.72 (1H, ddd, J 11.3, 5.8, 4.3 Hz, HB), 5.64 (1H, 
dd, J 11.3, 6.4, HC), 4.41 (1H, ddd, J 11.1, 7.9, 5.1 Hz, HD), 4.31 (1H, dt, J 11.1, 7.6 Hz, 
HD), 3.10-2.97 (3H, m, HE & HF & HG), 2.91 (1H, sept, J 7.0 Hz, HH), 2.87 (2H, sept, J 
7.0 Hz, HI), 2.74-2.59 (2H, m, HF & HG), 2.46 (1H, m, HJ), 2.43-2.34 (2H, m, HK & 
HL), 2.29 (1H, m, HL), 1.96-1.88 (2H, m, HM & HN), 1.83-1.71 (3H, m, HN & HO), 1.45 
(1H, m, HK), 1.26 (12H, d, J 7.0 Hz, HP), 1.25 (6H, d, J 7.0 Hz, HP’), 1.05 (3H, d, J 6.7 
Hz, HQ). 13C NMR (125 MHz, CDCl3): δ = 171.0 (C=O), 150.0 (C), 144.7 (2 x C), 
132.2 (CH), 130.7 (C), 129.4 (CH), 120.8 (2 x CH), 66.9 (CH), 63.8 (CH2), 55.2 (CH2), 
51.0 (CH2), 46.3 (CH), 34.4 (CH), 33.2 (CH2), 31.7 (CH), 31.5 (2 x CH), 28.5 (CH2), 
28.1 (CH2), 24.2 (4 x CH3), 24.0 (2 x CH3), 23.3 (CH2), 18.6 (CH3). HRMS (ESI) 
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Found: [M+H]+, 440.3524. C29H46NO2 requires [M+H]+, 440.3523. 
 
(R)-3-((9R,9aS)-Octahydro-1H-pyrrolo[1,2-a]azepin-9-yl)butyl 2,4,6-
triisopropylbenzoate (3) 
 
To a solution of 31 (373 mg, 0.85 mmol, 1.00 equiv.) in EtOAc (0.1 M, 8.5 mL) was 
added PtO2 (19.3 mg, 0.085 mmol, 0.10 equiv.) under a N2 atmosphere. The solution 
was purged with H2 (g) for 30 min, after which it was stirred under a H2 atmosphere for 
24 h. The solution was filtered through celite, washing copiously with EtOAc, then the 
solvent was removed under vacuum. The crude product was purified by column 
chromatography on silica gel, eluting with CH2Cl2:MeOH:NH4OH 96.9:3:0.1, to give 3 
as an oil (334 mg, 90%). [α]D (20 °C, CHCl3, c 1.0) = –10. FT-IR νmax (film)/cm-1: 
2962, 1718, 1264, 1076, 733. 1H NMR (500 MHz, CDCl3): δ = 7.02 (2H, s, HA), 4.40 
(1H, ddd, J 10.8, 7.8, 5.3 Hz, HB), 4.32 (1H, dt, J 10.8, 7.8 Hz, HB), 3.18 (1H, br m, 
HC), 3.06-2.99 (2H, m, HD & HE), 2.90 (1H, sept, J 7.0 Hz, HF), 2.86 (2H, sept, J 7.0 
Hz, HG), 2.78-2.64 (2H, m, HD & HE), 2.16 (1H, m, HH), 1.86-1.72 (4H, m, HI & HJ), 
1.70-1.60 (3H, m, HK & HL & HM), 1.55 (1H, m, HN), 1.52-1.41 (2H, m, HH & HN), 
1.32-1.19 (21H, m, HK & HO & HP & HP’), 0.97 (3H, d, J 6.5 Hz, HQ). 13C NMR (125 
MHz, CDCl3): δ = 171.0 (C=O), 150.1 (C), 144.7 (2 x C), 130.7 (C), 120.9 (2 x CH), 
65.3 (CH), 63.7 (CH2), 53.9 (CH2), 51.8 (CH2), 46.0 (CH), 34.4 (CH), 32.6 (CH2), 32.5 
(CH), 31.5 (2 x CH), 29.7 (CH2), 28.0 (CH2), 27.7 (CH2), 25.8 (CH2), 24.2 (4 x CH3), 
23.9 (2 x CH3), 23.7 (CH2), 18.3 (CH3). HRMS (ESI) Found: [M+H]+, 442.3678. 
C29H48NO2 requires [M+H]+, 442.3680. 
 
One-pot RCM-hydrogenation procedure from 17 to 3: 
17 (200 mg, 0.43 mmol, 1.00 equiv.) was dissolved in toluene (0.01 M, 45 mL). The 
solution was degassed, then camphorsulfonic acid (105 mg, 0.45 mmol, 1.05 equiv.) 
was added. The solution was stirred for 30 min, then Hoveyda-Grubbs 2nd Generation 
catalyst (53 mg, 0.085 mmol, 0.20 equiv.) was added. The solution was stirred at 80 °C 
for 5 h, then it was cooled to room temperature. PtO2 (10 mg, 0.043 mmol, 0.1 equiv.) 
was added under a N2 atmosphere. The solution was purged with H2 (g) for 30 min, 
after which it was stirred under a H2 atmosphere for 24 h. The solution was filtered 
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through celite, washing copiously with EtOAc, then the solvent was removed under 
vacuum. The crude product was purified by column chromatography on silica gel, 
eluting with CH2Cl2:MeOH:NH4OH 96.9:3:0.1, to give 3 as an oil (155 mg, 82%). 
  
	 SI-45 
7. Optimisation of the Asymmetric Lithiation of 3 
7.1. Initial in situ React-IR Monitoring 
 
To a three-necked round-bottomed flask equipped with a ReactIR probe was added a 
solution of TIB ester 3 (140 mg, 0.32 mmol, 1.00 equiv.) and (+)-sparteine (73 mg, 
0.07 mL, 0.32 mmol, 1.00 equiv.) in Et2O (1.5 mL). A peak at 1727 cm-1 was observed, 
which was assigned to the C=O bond stretch in 3. The solution was cooled to –78 °C 
and s-BuLi (1.3 M in hexanes, 0.24 mL, 0.32 mmol, 1.00 equiv.) was added dropwise. 
After 1 h no change in the IR signals was observed, which indicated that the lithiation to 
give 3a was not taking place. Upon addition of a second equivalent of s-BuLi, the peak 
at 1727 cm-1 started to decrease slowly, accompanied by the appearance of a peak at 
1633 cm-1, characteristic of the C=O bond stretch of lithiated TIB ester 3a. The reaction 
mixture was stirred for another 3 h, observing a very slow conversion, and after another 
2 h of no evolution the reaction was quenched with MeOD (0.1 mL). The reaction 
mixture was diluted with EtOAc (5 mL), water was added (5 mL) and the layers were 
separated. The organic layer was washed with Brine (2 x 5 mL) and the combined 
aqueous layers were extracted with EtOAc (3 x 5 mL). The organic layers were 
combined, dried over MgSO4 and concentrated under vacuum. After purification by 
column chromatography on silica gel, eluting with CH2Cl2:MeOH:NH4OH 99.9:0:0.1 to 
96.9:3:0.1, TIB ester 3 was recovered (110 mg, 79%) with <5% D incorporation 
observed by 1H NMR. 
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7.2. Optimization of the Asymmetric Lithiation of 3 Using (+)-Sparteine Surrogate 
General Procedure for the Asymmetric Lithiation of 3 – GP3 
 
3 (20 mg, 0.045 mmol, 1.0 equiv.) and (+)-sparteine surrogate (see Table 2 for equiv.) 
were dissolvent in the appropriate solvent (1 mL). The solution was cooled to the 
appropriate temperature and s-BuLi (1.3 M in hexanes, see Table 2 for equiv.) was 
added dropwise). The mixture was stirred for 5 h at the appropriate temperature, then 
Me3SnCl (1.0 M in hexane, 1.1 equiv. with respect to s-BuLi/(+)-sps) was added 
dropwise. The reaction mixture was stirred at –78 °C for 1 h then slowly warmed to 
room temperature. Aqueous KF (5 mL) was added and the layers were separated. The 
organic layer was washed with Brine (2 x 5 mL) and the combined aqueous layers were 
extracted with EtOAc (3 x 5 mL). The organic layers were combined, dried over 
MgSO4 and concentrated under vacuum. The ratio between 3 and stannane 27 was 
determined by 1H NMR analysis of the crude mixture. 
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–63
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b Reaction carried out in a 230 mg (0.50 mmol) scale under optimised 
   conditions (1 h lithiation - vide infra for ReactIR analysis)
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7.3. in situ React-IR monitoring 
 
To a three-necked round-bottomed flask equipped with a ReactIR probe was added a 
solution of TIB ester 3 (100 mg, 0.23 mmol, 1.00 equiv.) and (+)-sparteine surrogate 
(132 mg, 0.13 mL, 0.68 mmol, 3.00 equiv.) in CPME (3.0 mL). A peak at 1727 cm-1 
was observed, which was assigned to the C=O bond stretch in 3. The solution was 
cooled to –78 °C and s-BuLi (1.3 M in hexanes, 0.52 mL, 0.68 mmol, 3.00 equiv.) was 
added dropwise. This led to the gradual disappearance of the signal at 1727 cm-1 and the 
appearance of a new signal at 1633 cm-1, characteristic of the C=O bond stretch of 
lithiated TIB ester 3a. This signal rose to a plateau over a period of 20 min following 
completion of s-BuLi addition. After another 20 min, Me3SnCl (1.0 M in hexanes, 
0.76 mL, 0.76 mmol, 3.30 equiv.) was added dropwise. This led to the almost 
immediate disappearance of the signal at 1633 cm-1 and the simultaneous appearance of 
a third signal at 1703 cm-1, characteristic of the C=O bond stretch of stannane 27. The 
reaction mixture was stirred at –78 °C for 1 h then slowly warmed to room temperature. 
Aqueous KF (3 mL) was added and the layers were separated. The organic layer was 
washed with Brine (2 x 5 mL) and the combined aqueous layers were extracted with 
EtOAc (3 x 5 mL). The organic layers were combined, dried over MgSO4 and 
concentrated under vacuum. 1H NMR analysis of the crude product showed no presence 
of TIB ester 7, indicating that its lithiation was complete. The crude product was 
purified by column chromatography on silica gel, eluting with CH2Cl2:MeOH:NH4OH 
99.9:0:0.1 to 96.9:3:0.1, to give 27 as an oil (105 mg, 76%). 
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(1R,3R)-3-((9R,9aS)-octahydro-1H-pyrrolo[1,2-a]azepin-9-yl)-1-
(trimethylstannyl)butyl 2,4,6-triisopropylbenzoate (27) 
 
A solution of 3 (230 mg, 0.52 mmol, 1.00 equiv.) and (+)-sparteine surrogate (303 mg, 
0.30 mL, 1.56 mmol, 3.00 equiv.) in CPME (0.1 M, 5.0 mL) was cooled to –78 °C and 
s-BuLi (1.3 M in hexanes, 1.20 mL, 1.56 mmol, 3.00 equiv.) was added dropwise. The 
reaction mixture was stirred at –78 °C for 1 h, then Me3SnCl (1.0 M in hexanes, 
1.72 mL, 1.72 mmol, 3.30 equiv.) was added dropwise. The reaction mixture was stirred 
at –78 °C for 1 h then slowly warmed to room temperature. Aqueous KF (5 mL) was 
added and the layers were separated. The organic layer was washed with Brine 
(2 x 5 mL) and the combined aqueous layers were extracted with EtOAc (3 x 5 mL). 
The organic layers were combined, dried over MgSO4 and concentrated under vacuum. 
The crude product was purified by column chromatography on silica gel, eluting with 
CH2Cl2:MeOH:NH4OH 99.9:0:0.1 to 96.9:3:0.1, to give 27 as an oil (288 mg, 92%, 
94:6 d.r. as seen by 1H NMR). [α]D (20 °C, CHCl3, c 1.0) = –29. FT-IR νmax (film)/cm-
1: 2960, 1703, 1460, 1250, 876, 767. 1H NMR (500 MHz, CDCl3): δ = 7.01 (2H, s, 2 x 
CHA), 5.20 (1H, dd, J 9.5, 6.2 Hz, CHB), 3.89 (1H, m, CHC), 3.47 (1H, m, CH2D), 3.24 
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(2H, m, CH2E), 3.02 (1H, m, CH2D), 2.89 (1H, sept, J 6.9 Hz, CHF), 2.82 (2H, sept, J 6.9 
Hz, 2 x CHG), 2.15-1.34 (14H, m, CHH & CH2I & CH2J & CH2K & CH2L & CH2M & 
CH2N & CHO), 1.25 (12H, d, J 6.9 Hz, 4 x CH3P), 1.24 (6H, d, J 6.9 Hz, 2 x CH3P’), 0.99 
(3H, d, J 7.0 Hz, CH3Q), 0.24 (9H, s and d, J 53.0 Hz, 3 x CH3R). 13C NMR (125 MHz, 
CDCl3): δ = 171.3 (C=O), 150.0 (C), 144.8 (2 x C), 130.7 (C), 120.8 (2 x CH), 71.3 
(CH), 64.6 (CH), 53.4 (CH2), 50.7 (CH2), 44.9 (CH), 38.2 (CH2), 35.3 (CH), 34.4 (CH), 
31.5 (2 x CH), 28.5 (CH2), 27.7 (CH2), 26.5 (CH2), 24.4 (2 x CH3), 24.3 (4 x CH3), 23.9 
(CH2), 23.4 (CH2), 18.8 (CH3), –9.0 (CH3, s and d, J 330.6 Hz, and d, J 316.2 Hz) 
HRMS (ESI) Found: [M+H]+, 442.3678. C29H48NO2 requires [M+H]+, 442.3680. 
  
	 SI-51 
8. Synthesis of Building Block 4 
 
 
tert-Butyl 2-(hydroxymethyl)acrylate (32) 
 
Following a literature procedure,[13] tert-butyl acrylate (22) (1.00 g, 1.14 mL, 7.80 
mmol, 1.00 equiv.) was dissolved in H2O:dioxane (50 mL, 0.15 M). DABCO (2.62 g, 
23.4 mmol, 3.00 equiv.) and formaldehyde (37% w/w solution in H2O, 1.90 mL, 23.4 
mmol, 3.00 equiv.) were added and the solution was stirred at room temperature for 48 
h. Et2O (30 mL) was added and the layers were separated. The organic layer was 
washed with Brine (2 x 20 mL) and the combined aqueous layers were extracted with 
Et2O (3 x 20 mL). The organic layers were combined, dried over MgSO4 and 
concentrated under vacuum. The crude product was purified by column chromatography 
on silica gel, eluting with petrol:EtOAc 3:1, to give 32 as a colourless oil (1.04 g, 85%). 
FT-IR νmax (film)/cm-1: 3418 (broad), 2978, 1705, 1368, 1147, 1051, 847. 1H NMR 
(400 MHz, CDCl3): δ = 6.14 (1H, m), 5.73 (1H, dt, J 2.8, 1.3 Hz), 4.27 (2H, br m), 2.34 
(1H, br s), 1.49 (9H, s). 13C NMR (100 MHz, CDCl3): δ = 165.7 (C=O), 140.8 (C), 
124.8 (CH2), 81.4 (C), 62.8 (CH2), 28.1 (3 x CH3). LRMS (ESI) Found [M+Na]+, 
181.0840. Data in accordance with the literature.[13]  
 
tert-butyl 3-hydroxy-2-methylpropanoate (23) 
 
32 (100 mg, 0.63 mmol, 1.0 equiv.) was dissolved in CH2Cl2 (3 mL). 5% Palladium on 
charcoal (116 mg, 0.10 equiv. Pd) was added. The solution was placed under H2 
atmosphere (20 bar) for 2 h. The Pd salts were filtered through celite, washing with 
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CH2Cl2, to give crude rac-23 as an oil (50 mg, 50%), which was used in the next step 
without further purification. FT-IR νmax (film)/cm-1: 3442 (broad), 2977, 1724, 1367, 
1152, 1030, 846. 1H NMR (400 MHz, CDCl3): δ = 3.67 (1H, dd, J 11.2, 7.0 Hz), 3.63 
(1H, dd, J 11.2, 5.0 Hz), 2.54 (1H, ap. pd, J 7.1, 5.0 Hz), 1.45 (9H, s), 1.12 (3H, d, J 7 
Hz). 13C NMR (100 MHz, CDCl3): δ = 175.3 (C=O), 81.0 (C), 64.8 (CH2), 42.5 (CH), 
28.2 (3 x CH3), 13.6 (CH3). LRMS (ESI) Found [M+Na]+, 183.0992. Data in 
accordance with the literature.[13] 
 
tert-Butyl (R)-3-hydroxy-2-methylpropanoate [(R)-23] 
 
Following a literature procedure,[13] Ru(COD)(methylallyl)2 (10 mg, 0.02 mmol, 0.01 
equiv.) and (S)-Synphos (21 mg, 0.033 mmol, 0.011 equiv.) were added to a Schlenck 
tube, under N2 atmosphere, and dissolved in degassed CH2Cl2 (3 mL). The solution was 
cooled to 0 °C and HBF4·Et2O (0.17 M in degassed CH2Cl2, 0.05 mL solution, 
0.066 mmol, 0.022 equiv.) was added dropwise. The solution was stirred for 30 min at 
room temperature, at which time an orange suspension appeared. The solvent was 
removed under vacuum, and a solution of 32 (475 mg, 3.00 mmol, 1.00 equiv.) in 
degassed MeOH (9 mL) was added. The solution was placed under H2 atmosphere 
(5 bar) and stirred at room temperature for 24 h. After evaporation of the solvent, the 
crude product was purified by column chromatography on silica gel, eluting with 
petrol:EtOAc 3:1, to give 23 as a colourless oil (427 mg, 89%, 95: e.r. – determined 
after derivatisation to 23a, vide infra). [α]D (20 °C, CHCl3, c 1.0) = –12. Other data as 
above. Data in accordance with the literature.[13] 
 
3-(tert-butoxy)-2-methyl-3-oxopropyl benzoate (23a) 
 
Following a modified literature procedure[14], a solution of 23 (72 mg, 0.45 mmol, 
1.00 equiv.) in CH2Cl2:pyridine 2:1 (0.5 M, 0.3 mL) was cooled to 0 °C and benzoyl 
chloride (100 mg, 0.084 mL, 0.72 mmol, 1.50 equiv.) was added dropwise. The solution 
was warmed to room temperature and stirred for 6 h. Aqueous NH4Cl (0.5 mL) was 
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added and the layers were separated. The organic layer was washed with Brine (2 x 1 
mL) and the combined aqueous layers were extracted with CH2Cl2 (3 x 2 mL). The 
organic layers were combined, dried over MgSO4 and concentrated under vacuum. The 
crude product was purified by column chromatography on silica gel, eluting with 
petrol:EtOAc 99:1, to give 23a as an oil (80 mg, 68%). FT-IR νmax (film)/cm-1: 2977, 
1722, 1270, 710. 1H NMR (400 MHz, CDCl3): δ = 8.03 (2H, d, J 7.4 Hz, HA), 7.56 
(1H, t, J 7.4 Hz, HB), 7.35 (2H, t, J 7.4 Hz, HC), 4.44 (1H, dd, J 11.0, 7.3 Hz, HD), 4.39 
(1H, dd, J 11.0, 5.9 Hz, HD), 2.84 (1H, ap. sext., J 6.8 Hz, HE), 1.44 (9H, s, HF), 1.25 
(3H, d, J 6.8 Hz, HG). 13C NMR (100 MHz, CDCl3): δ =173.0 (C=O), 166.2 (C=O), 
132.9 (CH), 130.1 (C), 129.6 (2 x CH), 128.3 (2 x CH), 80.8 (C), 66.4 (CH2), 40.2(CH), 
28.0 (3 x CH3), 13.8 (CH3). HRMS (ESI) Found: [M+Na]+, 287.1259. C15H20NaO4 
requires [M+Na]+, 287.1254.  
 
Resolution of the enantiomers of 23 was achieved using chiral HPLC analysis (IA 
column, hexane:IPA 99:1 (10% of 10% IPA in hexane), 1 mL/min, 273 nm, tR 8.020 
min (S), 9.058 (R). 
 
 
(R)-3-(tert-Butoxy)-2-methyl-3-oxopropyl benzoate [(R)-23a] 
 
Following a modified literature procedure[14], a solution of (R)-23 (30 mg, 0.20 mmol, 
1.00 equiv.) in CH2Cl2:pyridine 2:1 (0.5 M, 0.3 mL) was cooled to 0 °C and benzoyl 
chloride (40 mg, 0.033 mL, 0.30 mmol, 1.50 equiv.) was added dropwise. The solution 
was warmed to room temperature and stirred for 6 h. Aqueous NH4Cl (0.5 mL) was 
added and the layers were separated. The organic layer was washed with Brine (2 x 1 
mL) and the combined aqueous layers were extracted with CH2Cl2 (3 x 2 mL). The 
organic layers were combined, dried over MgSO4 and concentrated under vacuum. The 
crude product was purified by column chromatography on silica gel, eluting with 
BzO Ot-Bu
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petrol:EtOAc 99:1, to give (R)-23a as an oil (40 mg, 81%, 95:5 e.r.). [α]D (20 °C, 
CHCl3, c 1.0) = –9. Other data as above.  
 
Chrial HPLC analysis (IA column, hexane:IPA 99:1 (10% of 10% IPA in hexane), 1 
mL/min, 273 nm, tR 8.020 min [(S), minor], 9.058 [(R), major]: 
 
tert-Butyl (S)-3-iodo-2-methylpropanoate (33) 
 
Following a modified literature procedure,[15] 23 (86 mg, 0.54 mmol, 1.00 equiv.) was 
dissolved in CH2Cl2 (6 mL). The flask was protected from light and triphenylphosphine 
(247 mg, 0.94 mmol, 1.50 equiv.), imidazole (73 mg, 1.08 mmol, 2.00 equiv.) and 
iodine (238 mg, 0.94 mmol, 1.50 equiv.) were added. The solution was stirred for 4 h at 
room temperature, then saturated aqueous Na2S2O3 (5 mL) was added and the layers 
were separated. The organic layer was washed with Brine (2 x 5 mL) and the combined 
aqueous layers were extracted with CH2Cl2 (3 x 5 mL). The organic layers were 
combined, dried over MgSO4 and concentrated under vacuum. The crude product was 
purified by column chromatography on silica gel, eluting with petrol:Et2O 95:5, to give 
33 as a colourless oil (130mg, 89%). [α]D (20 °C, CHCl3, c 1.0) = –12. FT-IR νmax 
(film)/cm-1: 2976, 1727, 1457, 1367, 1144, 846. 1H NMR (400 MHz, CDCl3): δ = 3.33 
(1H, dd, J 9.6, 6.5 Hz, HA), 3.22 (1H, dd, J 9.6, 6.5 Hz, HA), 2.65 (1H, ap. sext., J 6.5 
Hz, HB), 1.45 (9H, s, HC), 1.22 (3H, d, J 6.5 Hz, HD). 13C NMR (100 MHz, CDCl3): δ = 
170.9 (C=O), 79.5 (C), 41.3 (CH), 26.3 (3 x CH3), 16.4 (CH3), 6.1 (CH2). HRMS (ESI) 
could not be obtained. 
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tert-Butyl (R)-2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propanoate 
(4) 
 
To a solution of 33 (110 mg, 0.41 mmol, 1.00 equiv.) in Et2O (4 mL) was added i-
PrOB(pin) (91 mg, 0.10 mL, 0.49 mmol, 1.20 equiv.). The solution was cooled to 
−105 °C and t-BuLi (1.6 M in pentane, 0.51 mL, 0.82 mmol, 2.00 equiv.) was added 
dropwise. The solution was stirred for 10 min at –105 °C, then it was slowly warmed to 
room temperature. Water (5 mL) was added and the layers were separated. The organic 
layer was washed with Brine (2 x 5 mL) and the combined aqueous layers were 
extracted with Et2O (3 x 5 mL). The organic layers were combined, dried over MgSO4 
and concentrated under vacuum. The crude product was purified by column 
chromatography, eluting with petrol:Et2O 95:5, to give 4 as a colourless oil (75 mg, 
69%, 94:6 e.r.). [α]D (20 °C, CHCl3, c 1.0) = –3. FT-IR νmax (film)/cm-1: 2977, 1725, 
1367, 1140, 846, 755. 1H NMR (400 MHz, CDCl3): δ = 2.54 (1H, ap. sext, J 7.0 Hz, 
HA), 1.42 (9H, s, HB), 1.22 (6H, s, HC), 1.21 (6H, s, HC), 1.14 (3H, d, J 7.0 Hz, HD), 
1.07 (1H, dd, J 15.8, 7.0 Hz, HE), 0.85 (1H, dd, J 15.8, 7.0 Hz, HE). 13C NMR (100 
MHz, CDCl3): δ = 176.8 (C=O), 83.1 (2 x C), 79.6 (C), 36.4 (CH), 28.1 (3 x CH3), 24.9 
(4 x CH3), 19.6 (CH3). 11B NMR (96 MHz, CDCl3): δ = 33. HRMS (ESI) Found: 
[M+Na]+, 293.1904. C14H27BNaO4 requires [M+Na]+, 293.1897. 
 
e.r. Determination: A solution of 4 (50 mg, 0.19 mmol, 1.0 equiv.) in THF (1 mL) was 
cooled to 0 °C, then aqueous NaOH 2M:H2O2 30% (2:1, 1 mL) was added dropwise. 
The biphasic solution was stirred vigorously for 1 h. Water (5 mL) and Et2O (5 mL) 
were added and the layers were separated. The organic layer was washed with Brine (2 
x 3 mL) and the combined aqueous layers were extracted with Et2O (2 x 5 mL). The 
organic layers were combined, dried over MgSO4 and concentrated under vacuum. The 
crude product was purified by flash column chromatography on silica gel, eluting with 
petrol:EtOAc 3:1, to give (R)-23 as a colourless oil (70%). (R)-23 was then converted 
into benzoate (R)-23a following the procedure described above (98%). 
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Chiral HPLC analysis (IA column, hexane:IPA 99:1 (10% of 10% IPA in hexane), 1 
mL/min, 273 nm, tR 8.020 min [(S), minor], 9.058 [(R), major]: 
 
 	  
BzO Ot-Bu
O23a
BzO Ot-Bu
O(R)-23a
(after asymmetric
reduction, e.r. 95:5)
BzO Ot-Bu
O(R)-23a
(after B(pin)
oxidation, e.r. 94:6)
	 SI-57 
8.1. Model Lithiation-Borylation with Boronic Ester 4 
(2R,4S)-tert-Butyl 6-(4-methoxyphenyl)-2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)hexanoate (34) 
 
TIB ester 8a[4] (see TIB ester 8, section 2 for synthesis) (50 mg, 0.13 mmol, 1.30 equiv.) 
and (+)-sparteine (28 mg, 0.03 mL, 0.12 mmol, 1.20 equiv.) were dissolved in CPME 
(1.3 mL). The solution was cooled to –78 °C and s-BuLi (1.3 M in hexanes, 0.09 mL, 
0.12 mmol, 1.20 equiv.) was added dropwise. The solution was stirred at –78 °C for 3 h, 
then a solution of 4 (26 mg, 0.1 mmol, 1.00 equiv.) in CPME (0.3 mL) was added 
dropwise. The solution was stirred for 45 min at –78 °C, after which 11B NMR analysis 
of the crude mixture showed complete boronate complex formation [11B NMR 
(92.6 MHz, no solvent) δ = 7].  The solution was warmed to 105 °C and stirred for 3 h. 
11B NMR analysis of the crude mixture showed full product formation [11B NMR 
(92.6 MHz, no solvent) δ = 33]. Water (5 mL) and Et2O (5 mL) were added and the 
layers were separated. The organic layer was washed with Brine (2 x 5 mL) and the 
combined aqueous layers were extracted with Et2O (3 x 5 mL). The organic layers were 
combined, dried over MgSO4 and concentrated under vacuum. The crude product was 
purified by column chromatography on silica gel, eluting with petrol:EtOAc 97:3 to 
95:5, to give 34 as an oil (25 mg, 61%). [α]D (20 °C, CHCl3, c 1.0) = +2. FT-IR νmax 
(film)/cm-1: 2926, 1725, 1512, 1244, 1142, 1037, 753.  1H NMR (400 MHz, CDCl3): δ 
= 7.10 (2H, d, J 8.2 Hz, HA), 6.82 (2H, d, J 8.2 Hz, HB), 3.79 (3H, s, HC), 2.54 (2H, m, 
HD), 2.39 (1H, sext, J 7.0 Hz, HE), 1.83 (1H, m, HF), 1.69 (2H, m, HG), 1.49-1.37 (10H, 
m, HF & HH), 1.27 (12H, s, HI), 1.08 (3H, d, J 7.0 Hz, HJ), 0.87 (1H, m, HK). 13C NMR 
(100 MHz, CDCl3): δ = 176.3 (C=O), 157.6 (C), 135.0 (C), 129.2 (2 x CH), 113.7 (2 x 
CH), 83.0 (2 x C), 79.6 (C), 55.2 (CH3), 39.3 (CH), 34.9 (CH2), 34.6 (CH2), 33.4 (CH2), 
28.1 (3 x CH3), 24.9 (2 x CH3), 24.8 (2 x CH3), 16.9 (CH3). 11B NMR (96 MHz, 
CDCl3): δ = 33. HRMS (ESI) Found: [M+Na]+, 441.2779. C24H39BNaO5 requires 
[M+Na]+, 441.2787. 
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9. Synthesis of Building Block 26 
 
 
Methyl (S)-3-((tert-butyldimethylsilyl)oxy)-2-methylpropanoate (35) 
 
Following a literature procedure,[15] to a solution of methyl (S)-3-hydroxy-2-
methylpropanoate (24) (1.00 g, 0.934 mL, 8.47 mmol, 1.00 equiv.) in dichloromethane 
(40 mL) was added imidazole (1.15 g, 16.94 mmol, 2.00 equiv.) followed by tert-
butyldimethylsilyl chloride (1.53 g, 10.16 mmol, 1.20 equiv.). The solution was stirred 
at room temperature for 16 h, then aqueous NH4Cl (30 mL) was added. The layers were 
separated, the organic layer was washed with Brine (2 x 10 mL) and the combined 
aqueous layers were extracted with dichloromethane (3 x 10 mL). The organic layers 
were combined, dried over MgSO4 and concentrated under vacuum. The crude product 
was purified by column chromatography on silica gel, eluting with petrol:EtOAc 97:3, 
to give 35 as a colourless oil (1.97 g, 99%). 1H NMR (400 MHz, CDCl3): δ = 3.77 (1H, 
dd, J = 9.7, 6.8 Hz), 3.67 (3H, s), 3.64 (1H, dd, J = 9.7, 6.3 Hz), 2.65 (1H, sextet, J = 
6.9 Hz), 1.13 (3H, d, J = 6.9 Hz), 0.87 (9H, s), 0.03 (6H, s). 13C NMR (100 MHz, 
CDCl3): δ = 175.5 (C=O), 65.2 (CH2), 51.5 (CH3), 42.5 (CH), 25.8 (3 x CH3), 18.2 
(CH3), 13.5 (C), –5.5 (2 x CH3). Data in accordance with the literature. [15] 
 
(R)-3-((tert-Butyldimethylsilyl)oxy)-2-methylpropan-1-ol (36) 
 
Following a literature procedure,[15] a solution of 35 (2.0 g, 8.60 mmol, 1.00 equiv.) in 
dichloromethane (40 mL) was cooled down to –78 °C. DIBAL-H (1.0 M in CH2Cl2, 
25.8 mL, 25.8 mmol, 3.00 equiv.) was added dropwise to the solution, which was then 
stirred for 1 h at –78 °C. The solution was warmed to room temperature. Et2O (51.6 
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mL) was added, followed by water (2.3 mL), dropwise, while stirring vigorously. The 
solution was stirred for 30 min, then 1.3 M NaOH (7.0 mL) was added. The aluminium 
salts were filtered, washing with EtOAc. The solvent was removed under vacuum. The 
crude product was purified by column chromatography on silica gel, eluting with 
petrol:EtOAc 90:10 to 85:15, to give 36 as a colourless oil (1.65 g, 94%). 1H NMR 
(400 MHz, CDCl3): δ = 3.73 (1H, dd, J = 9.7, 4.5 Hz), 3.67-3.59 (2H, m), 3.54 (1H, dd, 
J = 9.7, 8.0 Hz), 1.94 (1H, m), 0.90 (9H, s), 0.83 (3H, d, J = 7.4 Hz), 0.07 (6H, s). 13C 
NMR (100 MHz, CDCl3): δ = 68.8 (CH2),68.3 (CH2), 37.0 (CH), 25.9 (3 x CH3), 18.2 
(CH3), 13.1 (C), −5.5 (2 x CH3). Data in accordance with the literature. [15] 
 
(S)-tert-Butyl(3-iodo-2-methylpropoxy)dimethylsilane (25) 
 
To a solution of 36 (200 mg, 0.98 mmol, 1.00 equiv.) in CH2Cl2 (10 mL), covered in Al 
foil, were added imidazole (133 mg, 1.96 mmol, 2.00 equiv.), triphenylphosphine 
(385 mg, 1.47 mmol, 1.50 equiv.) and iodine (373 mg, 1.47 mmol, 1.50 equiv.). The 
solution was stirred at room temperature for 4 h, then aqueous Na2S2O3 (10 mL) was 
added. The layers were separated, the organic layer was washed with Brine (2 x 5 mL) 
and the combined aqueous layers were extracted with CH2Cl2 (2 x 10 mL). The organic 
layers were combined, dried over MgSO4 and concentrated under vacuum. The crude 
product was purified by column chromatography on silica gel, eluting with neat pentane 
to pentane:Et2O 97:3, to give 26 as a colourless oil (280 mg, 91%). 1H NMR 
(400 MHz, CDCl3): δ = 3.53 (1H, dd, J = 10.1, 5.1 Hz), 3.40 (1H, dd, J = 10.1, 6.9 Hz), 
3.31 (1H, dd, J = 9.5, 5.1 Hz), 3.25 (1H, dd, J = 9.3, 5.6 Hz), 1.65 (1H, m), 0.95 (3H, d, 
J = 6.8 Hz), 0.90 (9H, s), 0.07 (6H, s). 13C NMR (100 MHz, CDCl3): δ = 66.7 (CH2), 
37.4 (CH), 25.9 (3 x CH3), 18.2 (CH3), 17.2 (C), 13.7 (CH2), -5.4 (2 x CH3). Data in 
accordance with the literature. [15] 
 
(R)-tert-Butyldimethyl(2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)propoxy)silane (26) 
 
A solution of 25 (530 mg, 1.69 mmol, 1.00 equiv.) and i-PrOB(pin) (377 mg, 0.42 mL, 
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2.03 mmol, 1.20 equiv.) in Et2O (10 mL) was cooled down to –105 °C, then t-BuLi 
(1.9 M in pentane, 1.78 mL, 3.37 mmol, 2.00 equiv.) was added. The solution was 
stirred at –105 °C for 10 min, then slowly let warm to room temperature. Aqueous 
NH4Cl (10 mL) was added and the layers were separated. The organic layer was washed 
with Brine (2 x 5 mL) and the combined aqueous layers were extracted with Et2O 
(3 x 5 mL). The organic layers were combined, dried over MgSO4 and concentrated 
under vacuum. The crude product was purified by column chromatography on silica gel, 
eluting with petrol:EtOAc 99.5:0.5, to give 26 as a colourless oil (435 mg, 82%). [α]D 
(20 °C, CHCl3, c 1.0) = +4. FT-IR νmax (film)/cm-1: 2929, 1370, 1145, 1082, 834, 773. 
1H NMR (400 MHz, CDCl3): δ = 3.43 (1H, dd, J = 9.6, 5.8 Hz, HA), 3.31 (1H, dd, J = 
9.6, 7.0 Hz, HA), 1.84 (1H, m, HB), 1.24 (12H, s, HC), 0.92 (3H, d, J = 6.5 Hz, HD), 0.89 
(9H, s, HE), 0.86 (1H, dd, J = 15.4, 5.8 Hz, HF), 0.58 (1H, dd, J = 15.4, 8.8 Hz, HF), 
0.03 (6H, s, HG). 13C NMR (100 MHz, CDCl3): δ = 100.0 (C), 82.8 (2 x C), 70.0 (CH2), 
32.2 (CH), 26.0 (3 x CH3), 24.9 (2 x CH3), 24.8 (2 x CH3), 19.0 (CH3), 18.0 (C) –5.33 
(2 x CH3). 11B NMR (96.2 MHz, CDCl3): δ = 33.4. HRMS (ESI) Found: [M+H]+, 
315.2515. C16H35BO3Si requires [M+H]+, 315.2525. 
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10. Endgame 
 
 
(2R,4S,6R)-1-((tert-Butyldimethylsilyl)oxy)-2-methyl-6-((9R,9aS)-octahydro-1H-
pyrrolo[1,2-a]azepin-9-yl)heptan-4-ol (21) 
 
 3 (250 mg, 0.57 mmol, 1.00 equiv.) and (+)-sparteine surrogate (330 mg, 0.33 mL, 
1.70 mmol, 3.00 equiv.) were dissolved in CPME (6 mL). The solution was cooled to 
−78 °C and s-BuLi (1.3 M in hexanes, 1.30 mL, 3.00 equiv.) was added dropwise. The 
solution was stirred at –78 °C for 1 h, then a solution of 26 (534 mg, 1.70 mmol, 
3.00 equiv.) in CPME (1 mL) was added dropwise. The solution was stirred for 45 min 
at –78 °C, after which 11B NMR analysis of the crude mixture showed complete 
boronate complex formation [11B NMR (92.6 MHz, no solvent) δ = 7].  The solution 
was warmed to 60 °C and stirred for 16 h. 11B NMR analysis of the crude mixture 
showed full product formation [11B NMR (92.6 MHz, no solvent) δ = 33]. CPME was 
removed under vacuum and THF (6 mL) was added. The solution was cooled to 0 °C 
and an aqueous solution of 2 M NaOH and 30% H2O2 (2:1 v/v, 6 mL) was added 
dropwise. The solution was stirred vigorously for 2 h at 0 °C, then it was warmed to 
room temperature and diluted with water (10 mL) and EtOAc (10 mL). The layers were 
separated, the organic layer was washed with Brine (2 x 10 mL) and the combined 
aqueous layers were extracted with EtOAc (3 x 10 mL). The organic layers were 
combined, dried over MgSO4 and concentrated under vacuum. The crude product was 
purified by column chromatography on silica gel, eluting with CHCl3:MeOH:NH4OH 
99.9:0:0.1 to 94.9:5:0.1, to give 21 as an oil (117 mg, 52%). [α]D (20 °C, CHCl3, 
N OTIB
H
3H
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c 1.0) = –2. FT-IR νmax (film)/cm-1: 3367, 2926, 1461, 1250, 1087, 834. 1H NMR (500 
MHz, CDCl3): δ = 3.77 (1H, m, HA), 3.54 (1H, dd, J 10.1, 5.3 Hz, HB), 3.44 (1H, dd, J 
10.1, 7.4 Hz, HB), 3.14-2.95 (3H, m, HC & HD & HE), 2.69-2.51 (2H, m, HD & HE), 
1.89-1.78 (3H, m, HF & HG & HH), 1.76-1.62 (6H, m, HG & HH & HI & HJ & HK), 1.52 
(2H, m, HL), 1.44-1.28 (6H, m, HM & HN & HO), 0.97 (3H, d, J 6.1 Hz, HP), 0.94-0.90 
(12H, m, HQ & HR), 0.09 (6H, s, HS). 13C NMR (125 MHz, CDCl3): δ = 69.3 (CH2), 
68.6 (CH), 65.4 (CH), 54.3 (CH2), 52.4 (CH2), 46.0 (CH), 43.1 (CH2), 42.2 (CH2), 34.1 
(CH), 29.7 (CH2), 28.3 (CH2), 28.0 (CH2), 26.0 (CH2), 25.9 (3 x CH3), 23.8 (CH2), 20.0 
(CH3), 18.3 (C), 17.8 (CH3), –5.4 (2 x CH3). HRMS (ESI) Found: [M+H]+, 398.3450. 
C23H48NO2Si requires [M+H]+, 398.3449. 
 
(2R,4S,6R)-2-Methyl-6-((9R,9aS)-octahydro-1H-pyrrolo[1,2-a]azepin-9-yl)heptane-
1,4-diol (37) 
 
21 (150 mg, 0.38 mmol, 1.0 equiv.) was dissolved in MeOH (4 mL). 1% aqueous HCl 
(0.5 mL) was added and the solution was stirred for 2 h at room temperature. Solid 
NaHCO3 was added, the solids were filtered washing with CH2Cl2 and the solvent was 
evaporated under vacuum, to give 37 as an oil (105 mg, quantitative crude yield), which 
was used in the next step without further purification. 
The crude product could also be purified by reverse phase flash chromatography (tR 7 
min) to give 37 as the formate salt, as an oil (79 mg, 73%). [α]D (20 °C, CHCl3, c 1.0) = 
–21. FT-IR νmax (film)/cm-1: 3319, 2926, 1594, 1456, 1337, 1036, 761. 1H NMR (500 
MHz, CDCl3): δ = 8.63 (1H, s, HCO2-) 4.00 (1H, m, HA), 3.90 (1H, m, HB), 3.66 (1H, 
dd, J 10.9, 3.8 Hz, HC), 3.56 (1H, m, HD), 3.40-3.30 (2H, m, HC & HD), 3.14 (1H, ap. 
dd, J 14.5, 6.6 Hz, HE), 2.94 (1H, m, HE), 2.41 (1H, m, HF), 2.08 (1H, m, HG), 2.03-1.83 
(7H, m, HG & HH & HI & HJ & HK), 1.76-1.57 (4H, m, HL & HM), 1.53-1.37 (4H, m, HN 
& HO), 0.90 (3H, d, J 6.8 Hz, HP), 0.89 (3H, d, J 7.3 Hz, HQ). 13C NMR (125 MHz, 
CDCl3): δ = 169.3 (formate HCO2-) 68.9 (CH2), 67.9 (CH), 64.4 (CH), 52.2 (CH2), 51.5 
(CH2), 44.6 (CH2), 42.0 (CH2), 39.1 (CH), 34.7 (2 x CH), 28.4 (CH2), 28.1 (CH2), 27.8 
(CH2), 23.7 (CH2), 22.9 (CH2), 18.6 (CH3), 17.7 (CH3). HRMS (ESI) Found: [M+H]+, 
284.2594. C17H34NO2 requires [M+H]+, 284.2584. 
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(3R,5S)-3-Methyl-5-((R)-2-((9R,9aS)-octahydro-1H-pyrrolo[1,2-a]azepin-9-
yl)propyl)dihydrofuran-2(3H)-one [(–)-stemaphylline, 1] 
 
To a solution of 37 (6 mg, 0.021 mmol, 1.0 equiv.) in toluene (2 mL) was added 
RuCl2(PPh3)3[16] (30 mg, 0.032 mmol, 1.5 equiv.). The mixture was stirred at room 
temperature for 16 h, then it was filtered through silica washing with 
CH2Cl2:MeOH:Et2NH 98.8:1.0:0.2. The crude product was purified by preparative TLC 
in an aluminium-backed plate pre-coated (0.25 mm) with Merck Silica Gel 60 F254. To 
visualise the product on the preparative TLC plate, a reference sample was run on the 
same plate, then cut and stained with KMnO4 (see picture below). 1 was obtained as an 
oil (4 mg, 67%). [α]D (20 °C, CHCl3, c 0.2) = –31 [lit.[17] for (–)-1, [α]D (20 °C, CHCl3, 
c 0.54) = –36.7]. FT-IR νmax (film)/cm-1: 2928, 1767, 1667, 1454, 1376, 1173, 1001, 
927.  1H NMR (600 MHz, CDCl3): δ = 4.40 (1H, m, H12), 3.01 (1H, m, H3), 2.94 (1H, 
m, H5), 2.89 (1H, m, H9a), 2.64 (1H, m, H14), 2.53-2.44 (3H, m, H3 & H5 & H13), 2.01 
(1H, m, H11), 1.82-1.74 (3H, m, H1 & H7), 1.72-1.63 (4H, m, H2 & H10 & H11), 1.61-
1.42 (6H, m, H6 & H8 & H9 & H13), 1.32 (1H, m, H7), 1.26 (3H, d, J 7.2 Hz, H16), 0.99 
(3H, d, J 6.6 Hz, H17). 13C NMR (150 MHz, CDCl3): δ = 179.8 (C15), 78.8 (CH12), 65.1 
(CH9a), 54.8 (CH23), 52.6 (CH25), 46.8 (CH9), 39.6 (CH211), 38.0 (CH213), 36.0 (CH14), 
32.5 (CH10), 28.9 (CH28), 28.5 (CH21), 27.9 (CH27), 26.0 (CH26), 24.0 (CH22), 19.6 
(CH317), 15.2 (CH316). HRMS (ESI) Found: [M+H]+, 280.2276. C17H34NO2 requires 
[M+H]+, 280.2271. Data in accordance with the literature[17] (See Table 3 for NMR data 
comparison between natural and synthetic (–)-1). 
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NOTE: Substantial degradation of the natural product was observed when it was kept 
as a solution in CDCl3 for several days. The following 1H NMR spectra correspond to 
the same sample of (–)-1; the bottom one was taken 72 h after the top one. 
 
Reference sampleCrude product
	 SI-65 
Table 3. Comparison of 1H and 13C NMR spectra between natural[17] and synthetic (–)-
stemaphylline [(–)-1]. 
  
δH δC
N4
CH317
H9a
H9
O
O
CH316
12
3
5
67
8
10
11
12 13
14
15
Natural
1.79 (m)
1.72 (m)
3.01 (m)
2.51 (m)
2.94 (m)
2.51 (m)
1.50 (m)
1.80 (m)
1.33 (m)
1.58 (m)
1.62 (m)
2.93 (m)
1.70 (m)
2.00 (m)
1.64 (m)
4.39 (m)
2.51 (m)
1.48 (m)
2.61 (m)
-
1.26 (d, J 7.0)
0.98 (d, J 6.5)
Synthetic
1.82-1.74 (m)
1.72-1.63 (m)
3.01 (m)
2.53-2.44 (m)
2.94 (m)
2.53-2.44 (m)
1.61-1.42 (m)
1.82-1.74 (m)
1.32 (m)
1.61-1.42 (m)
1.61-1.42 (m)
2.94 (m)
1.72-1.63 (m)
2.01 (m)
1.72-1.63 (m)
4.40 (m)
2.53-2.44 (m)
1.61-1.42 (m)
2.64 (m)
-
1.26 (d, J 7.0)
0.99 (d, J 6.4)
Natural
28.1
23.8
54.3
52.3
25.9
27.7
28.2
45.9
64.8
32.5
39.5
78.4
37.8
35.8
179.6
15.0
19.2
Synthetic
28.5
24.0
54.8
52.6
26.0
27.9
28.9
46.7
65.1
32.5
39.6
78.8
38.0
36.0
179.8
15.2
19.6
Position
1
2
3
5
6
7
8
9
9a
10
11
12
13
14
15
16
17
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11. 1H-NMR and 13C-NMR Spectra 
500 MHz, DMSO-d6, 90 °C 
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500 MHz, DMSO-d6, 90 °C
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400 MHz, CDCl3
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500 MHz, DMSO-d6, 90 °C 
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500 MHz, DMSO-d6, 90 °C 
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500 MHz, DMSO-d6, 90 °C 
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500 MHz, DMSO-d6, 90 °C 
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400 MHz, CDCl3 
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